The	DT	det	O
immunoglobulin	NN	compound	B-protein
heavy	JJ	amod	I-protein
chain	NN	compound	I-protein
(	-LRB-	punct	O
IgH	NN	appos	B-protein
)	-RRB-	punct	O
intronic	JJ	amod	O
enhancer	NN	nsubj	O
stimulates	VBZ	ROOT	O
transcription	NN	dobj	O
from	IN	case	O
functional	JJ	amod	O
promoters	NNS	nmod	O
in	IN	case	O
B	NN	compound	O
lymphocytes	NNS	nmod	O
but	CC	cc	O
not	RB	cc	O
other	JJ	amod	O
cell	NN	compound	O
types	NNS	conj	O
.	.	punct	O

[	-LRB-	punct	O
The	DT	det	O
effect	NN	ROOT	O
of	IN	case	O
24	CD	nummod	O
,	,	punct	O
25-dihydroxyvitamin	NN	compound	O
D3	NN	nmod	O
(	-LRB-	punct	O
dioxyvit	NN	appos	O
)	-RRB-	punct	O
on	IN	case	O
Ca	NN	compound	O
metabolism	NN	nmod	O
and	CC	cc	O
immune	JJ	amod	O
status	NN	conj	O
during	IN	case	O
chronic	JJ	amod	O
kidney	NN	compound	O
failure	NN	nmod	O
]	-RRB-	punct	O

We	PRP	nsubj	O
find	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
factor	NN	nsubj	O
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
E3	NN	compound	B-DNA
enhancer	NN	compound	I-DNA
motif	NN	nmod	I-DNA
,	,	punct	O
CATGTGGC	NN	appos	O
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
ubiquitous	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	ccomp	I-protein
.	.	punct	O

These	DT	det	O
studies	NNS	nsubj	O
are	VBP	cop	O
the	DT	det	O
first	JJ	ROOT	O
to	TO	mark	O
demonstrate	VB	xcomp	O
the	DT	det	O
significance	NN	dobj	O
of	IN	case	O
extrarenal	JJ	amod	B-protein
,	,	punct	I-protein
nonepithelial	JJ	dep	I-protein
mineralocorticoid	NN	compound	I-protein
receptors	NNS	nmod	I-protein
and	CC	cc	O
the	DT	det	O
related	JJ	amod	O
effector	NN	compound	O
mechanism	NN	conj	O
in	IN	case	O
different	JJ	amod	O
disorders	NNS	nmod	O
of	IN	case	O
the	DT	dep	O
water	NN	nmod	O
and	CC	cc	O
electrolyte	NN	conj	O
balance	NN	dep	O
in	IN	case	O
man	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
could	MD	aux	O
show	VB	ROOT	O
a	DT	det	O
decrease	NN	dobj	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
the	DT	det	O
phosphorylation	NN	conj	O
of	IN	case	O
Rap1	NN	compound	B-protein
protein	NN	nmod	I-protein
and	CC	cc	O
demonstrate	VBP	conj	O
a	DT	det	O
lower	JJR	amod	O
effect	NN	dobj	O
of	IN	case	O
C.	NN	compound	B-protein
Sub	NN	nmod	I-protein
.	.	punct	I-protein
on	IN	case	O
Ca2+	NN	compound	O
transport	NN	ROOT	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
enhancement	NN	nsubj	O
of	IN	case	O
IL-2	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	nmod	O
in	IN	case	O
neonates	NNS	nmod	O
was	VBD	cop	O
similar	JJ	ROOT	O
to	TO	case	O
adult	JJ	amod	O
levels	NNS	nmod	O
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
if	IN	mark	O
platelet	NN	compound	O
thromboxane	NN	compound	B-protein
receptors	NNS	nsubj	I-protein
are	VBP	cop	O
under	IN	case	O
transcriptional	JJ	amod	O
control	NN	advcl	O
,	,	punct	O
we	PRP	nsubj	O
isolated	VBD	ROOT	O
and	CC	cc	O
characterized	VBN	conj	O
human	JJ	amod	B-DNA
genomic	JJ	amod	I-DNA
DNA	NN	compound	I-DNA
clones	NNS	dobj	I-DNA
containing	VBG	acl	O
the	DT	det	O
5	CD	nummod	B-DNA
'	``	punct	I-DNA
flanking	JJ	amod	I-DNA
region	NN	dobj	I-DNA
of	IN	case	O
the	DT	det	O
thromboxane	NN	compound	B-DNA
receptor	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

In	IN	case	O
THP-1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
Fc	NN	compound	B-protein
gamma	NN	compound	I-protein
R	NN	compound	I-protein
cross-linking	NN	nsubj	O
induced	VBD	ROOT	O
NF-kappa	NN	compound	B-protein
B	NN	dobj	I-protein
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	acl:relcl	O
to	TO	mark	O
bind	VB	xcomp	O
to	TO	case	O
the	DT	det	O
regulatory	JJ	amod	B-DNA
region	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
long	JJ	amod	B-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
(	-LRB-	punct	O
LTR	NN	appos	B-DNA
)	-RRB-	punct	O
of	IN	case	O
HIV-1	NN	nmod	O
and	CC	cc	O
to	TO	mark	O
activate	VB	conj	O
HIV-1	NN	compound	O
transcription	NN	dobj	O
.	.	punct	O
Anti-TNF-alpha	NN	compound	B-protein
antibody	NN	nsubj	I-protein
but	CC	cc	O
not	RB	cc	O
anti-IL-1	NN	compound	B-protein
beta	NN	compound	I-protein
antibody	NN	conj	I-protein
strongly	RB	advmod	O
inhibited	VBD	ROOT	O
both	CC	cc:preconj	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
HIV-1-	NN	amod	O
LTR	NN	nmod:npmod	B-DNA
-driven	JJ	amod	O
transcription	NN	nmod	O
and	CC	cc	O
the	DT	det	O
induction	NN	conj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
by	IN	case	O
Fc	NN	compound	B-protein
gamma	NN	compound	I-protein
R	NN	compound	I-protein
cross-linking	NN	nmod	O
.	.	punct	O

The	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
LPS	NN	nmod	O
and	CC	cc	O
TNF-alpha	NN	conj	B-protein
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
their	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
induce	VB	acl	O
nuclear	JJ	amod	O
translocation	NN	dobj	O
of	IN	case	O
the	DT	det	O
DNA-binding	JJ	amod	B-protein
heterodimer	NN	compound	I-protein
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
(	-LRB-	punct	O
p50/p65	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
a	DT	det	O
specific	JJ	amod	O
sequence	NN	nmod	O
in	IN	case	O
the	DT	det	O
HIV-long	JJ	amod	B-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
inhibited	VBD	ROOT	O
the	DT	det	O
production	NN	dobj	O
of	IN	case	O
LTB4	NN	nmod	B-protein
(	-LRB-	punct	O
IC50	NN	nsubj	O
=	JJ	parataxis	O
0.5	CD	nummod	O
microM	NN	dobj	O
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
cytokines	NNS	conj	B-protein
IL-2	NN	dep	B-protein
,	,	punct	O
IL-6	NN	conj	B-protein
and	CC	cc	O
TNF	NN	compound	B-protein
alpha	NN	conj	I-protein
(	-LRB-	punct	O
IC50	NN	nsubj	O
=	JJ	acl:relcl	O
10-12	CD	nummod	O
microM	NN	dobj	O
)	-RRB-	punct	O
.	.	punct	O

There	EX	expl	O
are	VBP	ROOT	O
at	IN	case	O
least	JJS	nmod:npmod	O
six	CD	nummod	O
isomorphs	NNS	nsubj	B-protein
of	IN	case	O
p56	NN	nmod	B-protein
by	IN	case	O
two-dimensional	JJ	amod	O
gel	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

Effects	NNS	nsubjpass	O
similar	JJ	amod	O
to	TO	case	O
gp160	NN	nmod	B-protein
were	VBD	auxpass	O
seen	VBN	ROOT	O
with	IN	case	O
anti-CD4	JJ	amod	B-protein
mAb	NN	nmod	I-protein
.	.	punct	O

Type-II	JJ	amod	B-protein
estrogen-binding	JJ	amod	I-protein
sites	NNS	nsubjpass	I-protein
(	-LRB-	punct	O
type-II	JJ	amod	B-protein
EBS	NNS	appos	I-protein
)	-RRB-	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
demonstrated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_line
lymphoblastoid	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
IM-9	NN	nmod	B-cell_line
using	VBG	xcomp	O
a	DT	det	O
whole-cell	JJ	amod	O
assay	NN	dobj	O
with	IN	case	O
(	-LRB-	punct	O
6	CD	intj	O
,	,	punct	O
7-3H	NN	appos	O
)	-RRB-	punct	O
estradiol	NN	compound	O
(	-LRB-	punct	O
3H-E2	NN	nmod	O
)	-RRB-	punct	O
as	IN	case	O
tracer	NN	nmod	O
.	.	punct	O

Binding	VBG	amod	O
site	NN	compound	O
selection	NN	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
alternating	VBG	amod	B-protein
RCGCRYGCGY	NN	compound	I-protein
consensus	NN	nsubj	I-protein
constitutes	VBZ	ccomp	O
high-affinity	JJ	amod	O
IBR/F	NN	compound	B-DNA
binding	NN	compound	I-DNA
sites	NNS	dobj	I-DNA
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
direct-repeat	JJ	amod	B-DNA
palindrome	NN	nsubj	I-DNA
TGCGCATGCGCA	NN	dep	O
is	VBZ	cop	O
the	DT	det	O
optimal	JJ	amod	B-DNA
site	NN	conj	I-DNA
.	.	punct	O

The	DT	det	O
overall	JJ	amod	O
effect	NN	nsubj	O
of	IN	case	O
heat	NN	compound	O
shock	NN	nmod	O
on	IN	case	O
c-myc	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
level	NN	nmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
was	VBD	cop	O
a	DT	det	O
marked	JJ	amod	O
inhibition	NN	ROOT	O
of	IN	case	O
its	PRP$	nmod:poss	O
transcription	NN	nmod	O
.	.	punct	O

Similarly	RB	advmod	O
,	,	punct	O
an	DT	det	O
excess	NN	nsubjpass	O
of	IN	case	O
FK506	NN	nmod	O
is	VBZ	auxpass	O
needed	VBN	ROOT	O
to	TO	mark	O
revert	VB	xcomp	O
rapamycin-mediated	JJ	amod	O
inhibition	NN	dobj	O
of	IN	case	O
IL-2	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
proliferation	NN	nmod	O
.	.	punct	O

Four	CD	nummod	O
variants	NNS	nsubjpass	O
of	IN	case	O
changes	NNS	nmod	O
in	IN	case	O
the	DT	det	O
thyroid	NN	compound	O
status	NN	nmod	O
,	,	punct	O
characteristic	JJ	amod	O
of	IN	case	O
children	NNS	nmod	O
with	IN	case	O
different	JJ	amod	O
variants	NNS	nmod	O
of	IN	case	O
nephrotic	JJ	amod	O
syndrome	NN	nmod	O
were	VBD	auxpass	O
distinguished	VBN	ROOT	O
:	:	punct	O
1	LS	dep	O
)	-RRB-	punct	O
biochemical	JJ	amod	O
signs	NNS	dep	O
of	IN	case	O
primary	JJ	amod	O
hypothyroidism	NN	nmod	O
,	,	punct	O
2	LS	dep	O
)	-RRB-	punct	O
biochemical	JJ	amod	O
signs	NNS	conj	O
of	IN	case	O
secondary	JJ	amod	O
hypothyroidism	NN	nmod	O
,	,	punct	O
3	LS	dep	O
)	-RRB-	punct	O
low	JJ	amod	O
content	NN	appos	O
of	IN	case	O
T3	NN	nmod	O
,	,	punct	O
4	LS	dep	O
)	-RRB-	punct	O
dysfunction	NN	dep	O
of	IN	case	O
the	DT	det	O
hypophyseal	NN	amod	O
and	CC	cc	O
thyroid	NN	conj	O
system	NN	nmod	O
.	.	punct	O

Locus	NN	compound	B-DNA
control	NN	compound	I-DNA
regions	NNS	nsubj	I-DNA
(	-LRB-	punct	O
LCRs	NNS	appos	B-DNA
)	-RRB-	punct	O
are	VBP	cop	O
powerful	JJ	amod	O
assemblies	NNS	ROOT	O
of	IN	case	O
cis	NN	compound	B-DNA
elements	NNS	nmod	I-DNA
that	WDT	nsubj	O
organize	VBP	acl:relcl	O
the	DT	det	O
actions	NNS	dobj	O
of	IN	case	O
cell-type-specific	JJ	amod	B-protein
trans-acting	JJ	amod	I-protein
factors	NNS	nmod	I-protein
.	.	punct	O

Some	DT	nsubjpass	O
of	IN	case	O
these	DT	det	O
complexes	NNS	nmod	O
were	VBD	auxpass	O
demonstrated	VBN	ROOT	O
to	TO	mark	O
contain	VB	xcomp	O
NF-IL6	NN	dobj	B-protein
by	IN	mark	O
using	VBG	advcl	O
anti-C/EBP	JJ	amod	B-protein
beta	NN	compound	I-protein
Abs	NNS	dobj	I-protein
.	.	punct	O

Triggering	NN	nsubj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
interleukin-6	NN	compound	O
gene	NN	nmod	O
by	IN	case	O
interferon-gamma	NN	nmod	O
and	CC	cc	O
tumor	NN	compound	O
necrosis	NN	compound	O
factor-alpha	NN	conj	O
in	IN	case	O
monocytic	JJ	amod	O
cells	NNS	nmod	O
involves	VBZ	ROOT	O
cooperation	NN	dobj	O
between	IN	case	O
interferon	NN	compound	B-protein
regulatory	JJ	amod	I-protein
factor-1	NN	nmod	I-protein
,	,	punct	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
Sp1	NN	compound	B-protein
transcription	NN	compound	B-protein
factors	NNS	conj	I-protein
.	.	punct	O

At	IN	case	O
high	JJ	amod	O
concentration	NN	nmod	O
of	IN	case	O
NE	NN	nmod	O
,	,	punct	O
all	DT	nsubj	O
of	IN	case	O
the	DT	det	O
TR	NN	nmod	B-protein
bound	VBN	ROOT	O
to	TO	case	O
TREp	NN	nmod	B-DNA
was	VBD	auxpass	O
more	RBR	advmod	O
greatly	RB	advmod	O
retarded	VBN	conj	O
than	IN	case	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
NE	NN	nmod	O
.	.	punct	O

Mutation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
TCF-1	NN	compound	B-DNA
alpha	NN	compound	I-DNA
binding	NN	compound	I-DNA
site	NN	nmod	I-DNA
diminished	VBD	ROOT	O
enhancer	NN	compound	O
activity	NN	dobj	O
and	CC	cc	O
disrupted	VBD	conj	O
the	DT	det	O
synergism	NN	dobj	O
observed	VBN	acl	O
in	FW	compound	O
vivo	FW	advmod	O
between	IN	case	O
tandem	JJ	amod	B-DNA
enhancer	NN	compound	I-DNA
repeats	NNS	nmod	I-DNA
.	.	punct	O

The	DT	det	O
ds	JJ	amod	O
phosphorothioate	NN	compound	O
oligonucleotides	NNS	nsubj	O
probably	RB	advmod	O
compete	VBP	ROOT	O
for	IN	case	O
binding	NN	nmod	O
of	IN	case	O
specific	JJ	amod	O
transcription	NN	compound	O
factors	NNS	nmod	O
and	CC	cc	O
may	MD	aux	O
provide	VB	conj	O
anti-viral	JJ	amod	O
,	,	punct	O
immunosuppressive	JJ	conj	O
,	,	punct	O
or	CC	cc	O
other	JJ	amod	O
therapeutic	JJ	amod	O
effects	NNS	dobj	O
.	.	punct	O

1	LS	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	compound	O
production	NN	nsubj	O
by	IN	case	O
lavage	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
tuberculosis	NN	compound	O
patients	NNS	nmod	O
correlated	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
number	NN	nmod	O
of	IN	case	O
CD8+	JJ	amod	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
present	JJ	amod	O
but	CC	cc	O
not	RB	cc	O
other	JJ	amod	O
cell	NN	compound	O
types	NNS	conj	O
.	.	punct	O

Since	IN	mark	O
most	JJS	nsubjpass	O
of	IN	case	O
the	DT	det	O
actions	NNS	nmod	O
of	IN	case	O
vitamin	NN	compound	O
D	NN	nmod	O
are	VBP	auxpass	O
mediated	VBN	advcl	O
by	IN	case	O
its	PRP$	nmod:poss	O
receptors	NNS	nmod	O
(	-LRB-	punct	O
VDR	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
abnormalities	NNS	nsubjpass	O
of	IN	case	O
VDR	NN	nmod	B-protein
have	VBP	aux	O
been	VBN	auxpass	O
postulated	VBN	ROOT	O
in	IN	case	O
XLH	NN	nmod	O
.	.	punct	O

The	DT	det	O
virulence	NN	compound	O
defect	NN	nsubjpass	O
conferred	VBN	acl	O
by	IN	case	O
mutations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
phoP	NN	compound	B-DNA
-phoQ	CD	nummod	B-DNA
two-component	JJ	amod	O
regulatory	JJ	amod	O
system	NN	nmod	O
is	VBZ	auxpass	O
not	RB	neg	O
completely	RB	advmod	O
explained	VBN	ROOT	O
by	IN	case	O
alterations	NNS	nmod	O
in	IN	case	O
resistance	NN	nmod	O
to	TO	case	O
cationic	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
and	CC	cc	O
involves	VBZ	conj	O
the	DT	det	O
control	NN	dobj	O
of	IN	case	O
other	JJ	amod	O
proteins	NNS	nmod	O
necessary	JJ	amod	O
for	IN	case	O
S.	FW	compound	O
typhimurium	FW	compound	O
survival	NN	nmod	O
within	IN	case	O
macrophages	NNS	nmod	B-cell_type
.	.	punct	O

2	LS	dep	O
)	-RRB-	punct	O
The	DT	det	O
FI	NN	nsubj	O
of	IN	case	O
the	DT	det	O
chemotactic	JJ	amod	O
migration	NN	compound	O
rate	NN	nmod	O
of	IN	case	O
PMN	NN	nmod	B-cell_type
by	IN	case	O
cortisol	NN	nmod	O
also	RB	advmod	O
showed	VBD	ROOT	O
diurnal	JJ	amod	O
changes	NNS	dobj	O
which	WDT	nsubj	O
were	VBD	cop	O
synchronous	JJ	acl:relcl	O
with	IN	case	O
that	DT	nmod	O
of	IN	case	O
GR	NN	nmod	B-protein
.	.	punct	O

A	DT	det	O
regulatory	JJ	amod	B-DNA
element	NN	nsubj	I-DNA
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
interleukin	NN	compound	I-DNA
2	CD	nummod	I-DNA
gene	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
is	VBZ	cop	O
a	DT	det	O
binding	VBG	amod	B-DNA
site	NN	ROOT	I-DNA
for	IN	case	O
the	DT	det	O
zinc	NN	compound	B-protein
finger	NN	compound	I-protein
proteins	NNS	nmod	I-protein
Sp1	NN	dep	B-protein
and	CC	cc	O
EGR-1	NN	conj	B-protein
.	.	punct	O

In	IN	case	O
30	CD	nmod	O
of	IN	case	O
these	DT	det	O
cases	NNS	nmod	O
ER	NN	compound	B-protein
enzyme	NN	compound	O
immunoassay	NN	nsubjpass	O
(	-LRB-	punct	O
ER	NN	compound	B-protein
-EIA	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
also	RB	advmod	O
performed	VBN	ROOT	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
,	,	punct	O
using	VBG	xcomp	O
nuclear	JJ	amod	O
extracts	NNS	dobj	O
,	,	punct	O
recombinant	JJ	amod	B-protein
protein	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
a	DT	det	O
specific	JJ	amod	O
antiserum	NN	conj	O
against	IN	case	O
AML-1	NN	compound	B-protein
proteins	NNS	nmod	I-protein
in	IN	case	O
DNA-binding	JJ	amod	O
assays	NNS	nmod	O
,	,	punct	O
that	IN	mark	O
one	CD	nummod	O
member	NN	nsubj	O
of	IN	case	O
this	DT	det	O
family	NN	nmod	O
,	,	punct	O
AML-1B	NN	appos	B-protein
,	,	punct	O
binds	VBZ	acl:relcl	O
specifically	RB	advmod	O
to	TO	case	O
OSE2	NN	nmod	O
and	CC	cc	O
is	VBZ	cop	O
immunologically	RB	advmod	O
related	JJ	conj	O
to	TO	case	O
OSF2	NN	nmod	B-protein
,	,	punct	O
the	DT	det	O
factor	NN	appos	O
present	JJ	amod	O
in	IN	case	O
osteoblast	NN	compound	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
OSE2	NN	nmod	O
.	.	punct	O

To	TO	mark	O
further	RB	advmod	O
understand	VB	advcl	O
its	PRP$	nmod:poss	O
mechanism	NN	dobj	O
of	IN	case	O
action	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
HU	NN	nmod	O
on	IN	case	O
regulation	NN	nmod	O
of	IN	case	O
c-jun	NN	compound	B-DNA
expression	NN	nmod	O
prior	RB	case	O
to	TO	case	O
the	DT	det	O
onset	NN	nmod	O
of	IN	case	O
erythroid	JJ	amod	O
differentiation	NN	nmod	O
of	IN	case	O
K562	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

They	PRP	nsubj	O
inhibit	VBP	ROOT	O
synthesis	NN	dobj	O
of	IN	case	O
almost	RB	advmod	O
all	DT	amod	O
known	JJ	amod	O
cytokines	NNS	nmod	B-protein
and	CC	cc	O
of	IN	case	O
several	JJ	amod	O
cell	NN	compound	B-protein
surface	NN	compound	I-protein
molecules	NNS	conj	I-protein
required	VBN	acl	O
for	IN	case	O
immune	JJ	amod	O
function	NN	nmod	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
mechanism	NN	nsubjpass	O
underlying	VBG	acl	O
this	DT	det	O
activity	NN	dobj	O
has	VBZ	aux	O
been	VBN	auxpass	O
unclear.	NN	advmod	O
Here	RB	advmod	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
shown	VBN	conj	O
that	IN	mark	O
glucocorticoids	NNS	nsubj	O
are	VBP	cop	O
potent	JJ	amod	O
inhibitors	NNS	ccomp	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
(	-LRB-	punct	O
NF-kappa	NN	compound	B-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
activation	NN	nmod	O
in	IN	case	O
mice	NNS	nmod	O
and	CC	cc	O
cultured	VBN	amod	B-cell_line
cells	NNS	conj	I-cell_line
.	.	punct	O

Risk	NN	compound	O
factors	NNS	ROOT	O
for	IN	case	O
breast	NN	compound	O
recurrence	NN	nmod	O
in	IN	case	O
premenopausal	JJ	nmod	O
and	CC	cc	O
postmenopausal	JJ	conj	O
patients	NNS	dep	O
with	IN	case	O
ductal	JJ	amod	O
cancers	NNS	nmod	O
treated	VBN	acl	O
by	IN	case	O
conservation	NN	compound	O
therapy	NN	nmod	O
.	.	punct	O

PU.1	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	nsubj	O
and	CC	cc	O
PU.1	NN	compound	B-protein
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	conj	O
,	,	punct	O
as	IN	mark	O
measured	VBN	advcl	O
by	IN	case	O
Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
and	CC	cc	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	conj	O
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
were	VBD	cop	O
evident	JJ	ROOT	O
in	IN	case	O
cell	NN	compound	B-cell_line
lines	NNS	nmod	I-cell_line
representing	VBG	acl	O
pro-B	JJ	amod	B-cell_line
,	,	punct	I-cell_line
pre-B	JJ	conj	I-cell_line
,	,	punct	I-cell_line
and	CC	cc	I-cell_line
mature	JJ	conj	I-cell_line
B	NN	compound	I-cell_line
cells	NNS	dobj	I-cell_line
.	.	punct	O

The	DT	det	O
elevated	JJ	amod	O
rate	NN	nsubj	O
of	IN	case	O
ER	NN	compound	B-protein
content	NN	nmod	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
in	IN	case	O
14	CD	nummod	O
active	JJ	amod	O
SLE	NN	nmod	O
(	-LRB-	punct	O
92.9	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
was	VBD	cop	O
also	RB	advmod	O
higher	JJR	ROOT	O
than	IN	case	O
that	DT	nmod	O
in	IN	case	O
quieiescent	JJ	amod	O
patients	NNS	nmod	O
(	-LRB-	punct	O
23.1	CD	nummod	O
%	NN	dep	O
,	,	punct	O
P	NN	appos	O
less	JJR	amod	O
than	IN	case	O
0.001	CD	nmod	O
)	-RRB-	punct	O
and	CC	cc	O
in	IN	case	O
the	DT	det	O
controls	NNS	conj	O
(	-LRB-	punct	O
10	CD	nummod	O
%	NN	dep	O
,	,	punct	O
P	NN	appos	O
less	JJR	amod	O
than	IN	case	O
0.001	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Two	CD	nummod	O
distinct	JJ	amod	O
molecules	NNS	nsubjpass	O
,	,	punct	O
NFATp	NN	appos	B-protein
and	CC	cc	O
NFATc	NN	conj	B-protein
,	,	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
reported	VBN	ROOT	O
to	TO	mark	O
mediate	VB	xcomp	O
NFAT	NN	compound	B-protein
activity	NN	dobj	O
.	.	punct	O

The	DT	det	O
effect	NN	nsubj	O
of	IN	case	O
the	DT	det	O
hormone	NN	nmod	O
on	IN	case	O
the	DT	det	O
levels	NNS	nmod	O
of	IN	case	O
p50	NN	nmod	B-protein
was	VBD	cop	O
demonstrable	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
cytosolic	JJ	amod	O
and	CC	cc	O
nuclear	JJ	conj	O
compartments	NNS	nmod	O
;	:	punct	O
it	PRP	nsubj	O
required	VBD	parataxis	O
between	IN	case	O
4	CD	nummod	O
and	CC	cc	O
8	CD	conj	O
hr	NN	nmod	O
and	CC	cc	O
was	VBD	cop	O
specific	JJ	conj	O
,	,	punct	O
as	IN	mark	O
25-hydroxyvitamin	NN	compound	O
D3	NN	nsubj	O
and	CC	cc	O
24	CD	nummod	O
,	,	punct	O
25-dihydroxyvitamin	NN	compound	O
D3	NN	conj	O
were	VBD	cop	O
ineffective	JJ	advcl	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
E1A	NN	compound	B-protein
expression	NN	nsubj	O
marks	VBZ	ROOT	O
cells	NNS	dobj	O
for	IN	case	O
destruction	NN	nmod	O
by	IN	case	O
the	DT	det	O
host	NN	compound	O
NK	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
response	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
E7	NN	compound	B-protein
oncoprotein	NN	nsubj	I-protein
lacks	VBZ	parataxis	O
this	DT	det	O
activity	NN	dobj	O
.	.	punct	O

Relationship	NN	ROOT	O
between	IN	case	O
Rap1	NN	compound	B-protein
protein	NN	nmod	I-protein
phosphorylation	NN	dep	O
and	CC	cc	O
regulation	NN	conj	O
of	IN	case	O
Ca2+	NN	compound	O
transport	NN	nmod	O
in	IN	case	O
platelets	NNS	nmod	B-cell_type
:	:	punct	O
a	DT	det	O
new	JJ	amod	O
approach	NN	dep	O
.	.	punct	O

Heterogeneity	NN	ROOT	O
of	IN	case	O
antigen	NN	compound	B-protein
molecules	NNS	nmod	I-protein
recognized	VBN	acl	O
by	IN	case	O
anti-tax1	JJ	amod	B-protein
monoclonal	JJ	amod	I-protein
antibody	NN	nmod	I-protein
Lt-4	NN	dep	B-protein
in	IN	case	O
cell	NN	compound	O
lines	NNS	nmod	O
bearing	VBG	acl	O
human	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	dobj	O
I	CD	nummod	O
and	CC	cc	O
related	JJ	amod	O
retroviruses	NNS	conj	O
.	.	punct	O

T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
activation	NN	nsubj	O
results	VBZ	ROOT	O
in	IN	case	O
high	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
HIV	NN	compound	O
replication	NN	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
thought	VBN	conj	O
to	TO	mark	O
be	VB	cop	O
one	CD	nummod	O
mechanism	NN	xcomp	O
leading	VBG	acl	O
to	TO	case	O
the	DT	det	O
conversion	NN	nmod	O
from	IN	case	O
latent	JJ	nmod	O
to	TO	case	O
active	JJ	amod	O
viral	JJ	amod	O
infection	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
action	NN	nsubjpass	O
of	IN	case	O
IFN-alpha	NN	nmod	B-protein
in	IN	case	O
CML	NN	nmod	O
may	MD	aux	O
be	VB	auxpass	O
linked	VBN	ccomp	O
to	TO	case	O
a	DT	det	O
pathway	NN	nmod	O
that	WDT	nsubj	O
can	MD	aux	O
result	VB	acl:relcl	O
in	IN	case	O
posttranslational	JJ	amod	O
modification	NN	nmod	O
of	IN	case	O
nuclear	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

Prior	JJ	amod	O
analyses	NNS	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
enhancer	NN	nsubj	B-DNA
contains	VBZ	ccomp	O
a	DT	det	O
28-bp	JJ	amod	B-DNA
core	NN	compound	I-DNA
region	NN	dobj	I-DNA
and	CC	cc	O
local	JJ	amod	O
adjacent	JJ	amod	O
augmentative	JJ	amod	O
cis	NN	compound	B-DNA
elements	NNS	conj	I-DNA
.	.	punct	O

In	IN	case	O
animal	NN	compound	O
experiment	NN	nmod	O
,	,	punct	O
GCR	NN	nsubjpass	B-protein
of	IN	case	O
spleen	NN	compound	B-cell_type
lymphocytic	JJ	amod	I-cell_type
cell	NN	nmod	I-cell_type
was	VBD	auxpass	O
also	RB	advmod	O
measured	VBN	ROOT	O
in	IN	case	O
18	CD	nummod	O
aged	JJ	amod	O
rats	NNS	nmod	O
and	CC	cc	O
9	CD	nummod	O
young	JJ	amod	O
rats	NNS	conj	O
.	.	punct	O

The	DT	det	O
tumour	NN	compound	B-protein
suppressor	NN	compound	I-protein
p53	NN	nsubjpass	I-protein
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
regulate	VB	xcomp	O
this	DT	det	O
type	NN	dobj	O
of	IN	case	O
apoptosis	NN	nmod	O
in	IN	case	O
thymocytes	NNS	nmod	B-cell_type
,	,	punct	O
but	CC	cc	O
an	DT	det	O
as	RB	advmod	O
yet	RB	advmod	O
unknown	JJ	dep	O
,	,	punct	O
p53	NN	compound	B-protein
-independent	JJ	amod	O
pathway	NN	compound	O
(	-LRB-	punct	O
s	NNS	nsubj	O
)	-RRB-	punct	O
appears	VBZ	conj	O
to	TO	mark	O
mediate	VB	xcomp	O
the	DT	det	O
same	JJ	amod	O
event	NN	dobj	O
in	IN	case	O
mitogen-activated	JJ	amod	B-cell_line
mature	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
lymphocytes	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
reason	NN	nsubjpass	O
that	IN	mark	O
only	RB	advmod	O
certain	JJ	amod	O
individuals	NNS	nsubj	O
of	IN	case	O
particular	JJ	amod	O
major	JJ	amod	B-protein
histocompatibility	NN	compound	I-protein
complex	NN	compound	I-protein
(	-LRB-	punct	I-protein
MHC	NN	compound	I-protein
)	-RRB-	punct	I-protein
haplotypes	NNS	nmod	I-protein
can	MD	aux	O
mount	VB	relcl	O
T-cell	NN	compound	O
responses	NNS	dobj	O
against	IN	case	O
a	DT	det	O
given	JJ	amod	O
antigen	NN	nmod	O
of	IN	case	O
pathogens	NNS	nmod	O
is	VBZ	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
fact	NN	nmod	O
that	IN	mark	O
T-cell	NN	compound	B-protein
receptors	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
designed	VBN	ccomp	O
to	TO	mark	O
recognize	VB	xcomp	O
18-20	CD	nummod	O
residue-long	JJ	amod	O
peptide	NN	compound	O
fragments	NNS	dobj	O
sandwiched	JJ	acl	O
between	IN	case	O
two	CD	nummod	O
alpha-helices	NNS	nmod	B-protein
of	IN	case	O
class	NN	nmod	B-protein
I	CD	nummod	I-protein
or	CC	cc	O
class	NN	compound	O
II	CD	nummod	O
MHC	NN	compound	O
molecules	NNS	conj	O
.	.	punct	O

The	DT	det	O
mean	NN	compound	O
dissociation	NN	compound	O
constant	NN	nsubj	O
(	-LRB-	punct	O
Kd	NN	appos	O
)	-RRB-	punct	O
was	VBD	cop	O
similar	JJ	ROOT	O
in	IN	case	O
both	DT	det	O
sexes	NNS	nmod	O
(	-LRB-	punct	O
1.35	CD	nummod	O
+/-	CC	cc	O
0.70	CD	conj	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-10	CD	dep	O
)	-RRB-	punct	O
M	NN	dep	O
in	IN	case	O
males	NNS	nmod	O
,	,	punct	O
1.13	CD	nummod	O
+/-	CC	cc	O
0.66	CD	conj	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-10	CD	dep	O
)	-RRB-	punct	O
M	NN	nmod	O
in	IN	case	O
females	NNS	nmod	O
)	-RRB-	punct	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
concentration	NN	nsubj	O
of	IN	case	O
binding	VBG	amod	O
sites	NNS	nmod	O
(	-LRB-	punct	O
Nmax	NN	appos	O
)	-RRB-	punct	O
was	VBD	cop	O
significantly	RB	advmod	O
lower	JJR	conj	O
in	IN	case	O
females	NNS	nmod	O
(	-LRB-	punct	O
2.32	CD	nummod	O
+/-	CC	cc	O
0.92	CD	conj	O
fmol/10	NN	compound	O
(	-LRB-	punct	O
7	CD	dep	O
)	-RRB-	punct	O
PBMC	NN	dep	B-cell_type
vs	CC	cc	O
4.43	CD	nummod	O
+/-	CC	cc	O
1.38	CD	conj	O
fmol/10	NN	compound	O
(	-LRB-	punct	O
7	CD	appos	O
)	-RRB-	punct	O
PBMC	NN	conj	B-cell_type
in	IN	case	O
males	NNS	nmod	O
;	:	punct	O
p	NN	nsubj	O
=	JJ	parataxis	O
0.0001	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

This	DT	det	O
inhibition	NN	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
induction	NN	nmod	O
of	IN	case	O
the	DT	det	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	compound	O
inhibitory	JJ	amod	O
protein	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
traps	VBZ	acl:relcl	O
activated	VBD	amod	O
NF-kappa	NN	compound	B-protein
B	NN	dobj	I-protein
in	IN	case	O
inactive	JJ	amod	B-protein
cytoplasmic	JJ	amod	I-protein
complexes	NNS	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
hypothesized	VBD	ROOT	O
that	IN	mark	O
adherence	NN	nsubj	O
itself	PRP	dep	O
might	MD	aux	O
be	VB	cop	O
an	DT	det	O
important	JJ	amod	O
trigger	NN	ccomp	O
for	IN	case	O
a	DT	det	O
sequence	NN	nmod	O
of	IN	case	O
gene	NN	compound	O
activation	NN	nmod	O
culminating	VBG	acl	O
in	IN	case	O
cells	NNS	nmod	O
with	IN	case	O
increased	VBN	amod	O
mRNA	NN	nmod	B-RNA
encoding	VBG	acl	O
profibrotic	JJ	amod	O
growth	NN	compound	B-protein
factors	NNS	dobj	I-protein
such	JJ	case	O
as	IN	mwe	O
platelet-derived	JJ	amod	B-protein
growth	NN	compound	I-protein
factor	NN	compound	I-protein
B	NN	compound	I-protein
subunit	NN	nmod	I-protein
(	-LRB-	punct	O
PDGF	NN	compound	B-protein
[	-LRB-	punct	I-protein
B	NN	appos	I-protein
]	-RRB-	punct	I-protein
)	-RRB-	punct	O
and	CC	cc	O
transforming	VBG	amod	B-protein
growth	NN	compound	I-protein
factor-beta	NN	conj	I-protein
(	-LRB-	punct	O
TGF-beta	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
Id2	NN	compound	O
and	CC	cc	O
Id3	NN	conj	O
mRNA	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Anti-immunoglobulin	NN	compound	B-protein
M	NN	nsubj	I-protein
activates	VBZ	ROOT	O
nuclear	JJ	amod	B-protein
calcium/calmodulin-dependent	JJ	amod	I-protein
protein	NN	compound	I-protein
kinase	NN	dobj	I-protein
II	CD	nummod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

This	DT	det	O
disproportionate	JJ	amod	O
occurrence	NN	nsubj	O
in	IN	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	case	O
lupus	NN	compound	O
patients	NNS	nmod	O
indicates	VBZ	ROOT	O
that	IN	mark	O
these	DT	det	O
RFLPs	NNS	nsubj	B-DNA
are	VBP	cop	O
not	RB	neg	O
disease	NN	compound	O
susceptibility	NN	compound	O
markers	NNS	ccomp	O
,	,	punct	O
but	CC	cc	O
rather	RB	cc	O
are	VBP	cop	O
important	JJ	amod	O
markers	NNS	conj	O
for	IN	case	O
TCR	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
whose	WP$	nmod:poss	O
products	NNS	nsubjpass	O
are	VBP	auxpass	O
involved	VBN	acl:relcl	O
in	IN	case	O
the	DT	det	O
production	NN	nmod	O
of	IN	case	O
anti-Ro	NNS	compound	B-protein
(	-LRB-	punct	I-protein
SSA	NN	appos	I-protein
)	-RRB-	punct	I-protein
antibodies	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
MZF-1	NN	compound	B-DNA
binding	NN	compound	I-DNA
sites	NNS	nsubj	I-DNA
are	VBP	cop	O
present	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
promoters	NNS	nmod	B-DNA
of	IN	case	O
several	JJ	amod	O
genes	NNS	nmod	B-DNA
expressed	VBN	acl	O
during	IN	case	O
myeloid	JJ	amod	O
differentiation	NN	nmod	O
,	,	punct	O
including	VBG	case	O
the	DT	det	O
CD34	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

In	IN	case	O
a	DT	det	O
non-parametric	JJ	amod	O
test	NN	nmod	O
(	-LRB-	punct	O
Kruskal-Wallis	NN	appos	O
)	-RRB-	punct	O
a	DT	det	O
strong	JJ	amod	O
negative	JJ	amod	O
association	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
high	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
c-erbB2	NN	compound	B-DNA
amplification	NN	nmod	O
and	CC	cc	O
absence	NN	conj	O
of	IN	case	O
estrogen	NN	compound	O
receptor	NN	compound	O
(	-LRB-	punct	O
ER	NN	appos	O
)	-RRB-	punct	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
.0009	CD	dep	O
)	-RRB-	punct	O
or	CC	cc	O
progesterone	NN	compound	B-protein
receptor	NN	conj	I-protein
(	-LRB-	punct	O
PR	NN	appos	B-protein
)	-RRB-	punct	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
.011	CD	dep	O
)	-RRB-	punct	O
expression	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
Cu2+	NN	nsubj	O
inhibits	VBZ	ccomp	O
the	DT	det	O
release	NN	dobj	O
of	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
by	IN	case	O
blockade	NN	nmod	O
of	IN	case	O
a	DT	det	O
signal	NN	nmod	O
leading	VBG	acl	O
to	TO	case	O
the	DT	det	O
phosphorylation	NN	nmod	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
human	JJ	amod	B-DNA
T-cell	NN	compound	I-DNA
leukemia	NN	compound	I-DNA
virus	NN	compound	I-DNA
type	NN	compound	I-DNA
I	CD	nummod	I-DNA
(	-LRB-	punct	I-DNA
HTLV-I	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
promoter	NN	nsubj	I-DNA
contains	VBZ	ROOT	O
three	CD	nummod	O
copies	NNS	dobj	O
of	IN	case	O
imperfect	JJ	compound	O
repeats	NNS	nmod	O
of	IN	case	O
a	DT	det	O
21-base	JJ	amod	O
pair	NN	compound	O
sequence	NN	nmod	O
designated	VBN	acl	O
here	RB	advmod	O
as	IN	case	O
TRE	NN	nmod	B-DNA
(	-LRB-	punct	O
Tax-response	JJ	amod	B-DNA
element	NN	appos	I-DNA
)	-RRB-	punct	O
that	WDT	nsubj	O
is	VBZ	cop	O
responsive	JJ	acl:relcl	O
to	TO	case	O
the	DT	det	O
virally	RB	advmod	B-protein
encoded	VBN	amod	I-protein
transactivator	NN	compound	I-protein
protein	NN	compound	I-protein
Tax	NN	nmod	B-protein
.	.	punct	O

Transcription	NN	compound	B-protein
factors	NNS	nsubjpass	I-protein
belonging	VBG	acl	O
to	TO	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
family	NN	nmod	I-protein
are	VBP	auxpass	O
controlled	VBN	ROOT	O
by	IN	case	O
inhibitory	JJ	amod	B-protein
I	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
mainly	RB	advmod	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	appos	I-protein
and	CC	cc	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
beta	NN	conj	I-protein
.	.	punct	O

Modulation	NN	nsubj	O
of	IN	case	O
these	DT	det	O
events	NNS	nmod	O
at	IN	case	O
the	DT	det	O
time	NN	nmod	O
of	IN	case	O
adherence	NN	nmod	O
offers	VBZ	ROOT	O
a	DT	det	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
differential	JJ	amod	O
priming	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
may	MD	aux	O
be	VB	auxpass	O
accomplished	VBN	acl:relcl	O
.	.	punct	O

Previous	JJ	amod	O
transfection	NN	compound	O
studies	NNS	nsubj	O
of	IN	case	O
HIV	NN	compound	B-DNA
LTR	NN	compound	I-DNA
constructs	NNS	nmod	I-DNA
linked	VBN	acl	O
to	TO	case	O
the	DT	det	O
chloramphenicol	NN	compound	B-DNA
acetyltransferase	NN	compound	I-DNA
gene	NN	nmod	I-DNA
indicated	VBD	ROOT	O
that	IN	mark	O
multiple	JJ	amod	O
regulatory	JJ	amod	B-DNA
regions	NNS	nsubj	I-DNA
including	VBG	case	O
the	DT	det	O
enhancer	NN	nmod	B-DNA
,	,	punct	O
SP1	NN	conj	B-DNA
,	,	punct	O
TATA	NN	conj	B-DNA
and	CC	cc	O
TAR	NN	compound	B-DNA
regions	NNS	conj	I-DNA
were	VBD	cop	O
important	JJ	ccomp	O
for	IN	case	O
HIV	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Northern	NN	compound	O
(	-LRB-	punct	O
RNA	NN	appos	O
)	-RRB-	punct	O
blots	NNS	nsubj	O
and	CC	cc	O
binding	NN	compound	O
assays	NNS	conj	O
showed	VBD	ROOT	O
that	IN	mark	O
NF-IL6	NN	nsubj	B-protein
is	VBZ	cop	O
the	DT	det	O
only	RB	advmod	O
known	JJ	amod	O
C/EBP	NN	compound	B-protein
family	NN	compound	I-protein
member	NN	ccomp	I-protein
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
increased	VBN	acl:relcl	O
when	WRB	advmod	O
U937	NN	compound	B-cell_line
cells	NNS	nsubjpass	I-cell_line
are	VBP	auxpass	O
activated	VBN	advcl	O
.	.	punct	O

This	DT	det	O
cDNA	NN	compound	B-DNA
clone	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
isolated	VBN	ROOT	O
by	IN	case	O
expression	NN	compound	O
cDNA	NN	compound	B-DNA
cloning	NN	nmod	O
,	,	punct	O
and	CC	cc	O
encodes	VBZ	conj	O
the	DT	det	O
human	JJ	amod	B-protein
c-Jun	NN	compound	I-protein
protein	NN	dobj	I-protein
,	,	punct	O
which	WDT	nsubj	O
together	RB	advmod	O
with	IN	case	O
c-Fos	NN	nmod	B-protein
forms	VBZ	acl:relcl	O
the	DT	det	O
heterodimeric	JJ	amod	B-protein
activator	NN	compound	I-protein
protein-1	NN	compound	I-protein
transcription	NN	compound	I-protein
complex	NN	dobj	I-protein
.	.	punct	O

Transcriptional	JJ	amod	O
efficiency	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
MSV	NN	compound	B-DNA
LTR	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
containing	VBG	acl	O
this	DT	det	O
disrupted	VBN	amod	O
ets-1	NN	compound	B-DNA
binding	NN	compound	I-DNA
site	NN	dobj	I-DNA
was	VBD	auxpass	O
compared	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
a	DT	det	O
wild-type	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA
in	IN	case	O
mouse	NN	compound	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
in	IN	case	O
culture	NN	nmod	O
,	,	punct	O
and	CC	cc	O
15-	CD	compound	O
to	TO	dep	O
20-fold	JJ	amod	O
reduction	NN	nsubjpass	O
in	IN	case	O
expression	NN	nmod	O
of	IN	case	O
a	DT	det	O
reporter	NN	compound	B-DNA
gene	NN	nmod	I-DNA
was	VBD	auxpass	O
observed	VBN	conj	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
the	DT	det	O
phosphorylation	NN	nsubjpass	O
of	IN	case	O
Rex	NN	nmod	B-protein
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
viral	JJ	amod	O
RNA	NN	compound	O
partition	NN	nmod	O
of	IN	case	O
HTLV-I	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
in	IN	case	O
3	CD	nummod	O
postmenopausal	JJ	amod	O
patients	NNS	nmod	O
a	DT	det	O
short	JJ	amod	O
course	NN	nsubj	O
of	IN	case	O
estrogen	NN	nmod	O
or	CC	cc	O
tamoxifen	NN	conj	O
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
marked	JJ	amod	O
increase	NN	nmod	O
of	IN	case	O
type	NN	compound	B-protein
II	CD	nummod	I-protein
EBS	NNS	compound	I-protein
levels	NNS	nmod	O
.	.	punct	O

Purified	VBN	amod	O
OTF1	NN	nsubj	B-protein
from	IN	case	O
HeLa	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
OTF1	NN	conj	B-protein
and	CC	cc	O
OTF2	NN	conj	B-protein
from	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
bound	VBD	ROOT	O
to	TO	case	O
identical	JJ	amod	O
sequences	NNS	nmod	O
within	IN	case	O
the	DT	det	O
heavy-chain	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
dissociation	NN	compound	O
constant	NN	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
affected	VBN	ROOT	O
by	IN	case	O
methylprednisolone	NN	compound	O
treatment	NN	nmod	O
in	IN	case	O
either	DT	det	O
group	NN	nmod	O
.	.	punct	O

In	IN	case	O
Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
,	,	punct	O
mRNA	NN	compound	B-RNA
species	NNS	nsubjpass	I-RNA
of	IN	case	O
approximately	RB	advmod	O
1.8	CD	nummod	O
kilobases	NNS	nmod	O
that	WDT	nsubj	O
hybridized	VBD	acl:relcl	O
with	IN	case	O
human	JJ	amod	B-DNA
FKBP	NN	compound	I-DNA
cDNA	NN	nmod	I-DNA
were	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
poly	NN	compound	B-RNA
(	-LRB-	punct	I-RNA
A	NN	nmod	I-RNA
)	-RRB-	punct	I-RNA
+	CC	cc	I-RNA
RNAs	NNS	conj	I-RNA
from	IN	case	O
brain	NN	nmod	O
,	,	punct	O
lung	NN	conj	O
,	,	punct	O
liver	NN	conj	O
,	,	punct	O
and	CC	cc	O
placental	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
and	CC	cc	O
leukocytes	NNS	conj	B-cell_type
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
to	TO	case	O
the	DT	det	O
onset	NN	nmod	O
of	IN	case	O
differentiation	NN	nmod	O
,	,	punct	O
cell	NN	compound	O
death	NN	nsubjpass	O
was	VBD	auxpass	O
induced	VBN	ROOT	O
with	IN	case	O
typical	JJ	amod	O
apoptotic	JJ	amod	O
features	NNS	nmod	O
.	.	punct	O

These	DT	det	O
genes	NNS	nsubj	O
may	MD	aux	O
then	RB	advmod	O
play	VB	ROOT	O
a	DT	det	O
role	NN	dobj	O
in	IN	mark	O
altering	VBG	advcl	O
the	DT	det	O
physiologic	JJ	amod	O
status	NN	dobj	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
CSF	NN	nmod	B-protein
.	.	punct	O

Characterization	NN	ROOT	O
of	IN	case	O
5	CD	nummod	B-DNA
'	``	punct	I-DNA
end	NN	nmod	I-DNA
of	IN	case	I-DNA
human	JJ	amod	I-DNA
thromboxane	NN	compound	I-DNA
receptor	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

When	WRB	advmod	O
tested	VBN	advcl	O
in	IN	case	O
a	DT	det	O
radioreceptor	NN	compound	O
assay	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
leukocytes	NNS	nmod	I-cell_type
the	DT	det	O
synthesized	VBN	amod	O
compounds	NNS	nsubj	O
showed	VBD	ROOT	O
only	RB	advmod	O
low	JJ	amod	O
relative	JJ	amod	O
binding	NN	compound	O
affinities	NNS	dobj	O
(	-LRB-	punct	O
RBA	NNS	appos	O
)	-RRB-	punct	O
to	TO	case	O
type	NN	compound	B-protein
1	CD	nummod	I-protein
receptor	NN	nmod	I-protein
,	,	punct	O
the	DT	det	O
highest	JJS	nsubj	O
being	VBG	cop	O
0.72	CD	nummod	O
%	NN	appos	O
for	IN	case	O
13	CD	nmod	O
(	-LRB-	punct	O
aldosterone	NN	appos	O
=	JJ	amod	O
100	CD	nummod	O
%	NN	dep	O
)	-RRB-	punct	O
.	.	punct	O

Deletion	NN	compound	O
mutation	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
HIV-2	NN	compound	B-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
(	-LRB-	punct	O
LTR	NN	appos	B-DNA
)	-RRB-	punct	O
suggests	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
element	NN	nsubj	O
that	WDT	nsubj	O
responds	VBZ	acl:relcl	O
to	TO	case	O
CMV	NN	compound	O
transactivation	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
CD4+	JJ	amod	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
is	VBZ	cop	O
either	CC	cc:preconj	O
a	DT	det	O
diffuse	JJ	amod	O
one	CD	ccomp	O
or	CC	cc	O
located	JJ	conj	O
downstream	RB	advmod	O
of	IN	case	O
the	DT	det	O
HIV-2	NN	compound	B-DNA
enhancer	NN	compound	I-DNA
element	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
action	NN	nsubjpass	O
of	IN	case	O
physiological	JJ	amod	O
and	CC	cc	O
pharmacological	JJ	conj	O
concentration	NN	nmod	O
of	IN	case	O
GC	NN	nmod	O
may	MD	aux	O
be	VB	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
low	JJ	amod	B-protein
affinity	NN	nmod:npmod	I-protein
specific	JJ	amod	I-protein
binding	VBG	amod	I-protein
sites	NNS	nmod	I-protein
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

Strains	NNS	nsubj	O
with	IN	case	O
mutations	NNS	nmod	O
in	IN	case	O
either	CC	det	O
gene	NN	nmod	O
of	IN	case	O
the	DT	det	O
regulatory	JJ	amod	B-DNA
pair	NN	nmod	I-DNA
(	-LRB-	punct	O
phoP	NN	compound	B-DNA
[	-LRB-	punct	O
transcriptional	JJ	amod	B-DNA
activator	NN	dep	I-DNA
]	-RRB-	punct	O
or	CC	cc	O
phoQ	NN	compound	B-DNA
[	-LRB-	punct	O
membrane	NN	compound	B-protein
sensor	NN	compound	I-protein
kinase	NN	conj	I-protein
]	-RRB-	punct	O
)	-RRB-	punct	O
had	VBD	aux	O
increased	VBN	ROOT	O
sensitivities	NNS	dobj	O
to	TO	case	O
defensin	NN	nmod	B-protein
.	.	punct	O

Addition	NN	ROOT	O
of	IN	case	O
a	DT	det	O
highly	RB	advmod	O
enriched	JJ	amod	O
preparation	NN	nmod	O
of	IN	case	O
OTF-1	NN	nmod	B-protein
made	VBN	acl	O
from	IN	case	O
one	CD	nmod	O
of	IN	case	O
these	DT	det	O
pre-B	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
or	CC	cc	O
from	IN	case	O
HeLa	NN	compound	B-cell_line
cells	NNS	conj	I-cell_line
specifically	RB	advmod	O
stimulated	VBD	acl	O
in	FW	amod	O
vitro	FW	dep	O
transcription	NN	dobj	O
of	IN	case	O
an	DT	det	O
immunoglobulin	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Prolactin	NN	compound	B-protein
and	CC	cc	O
interleukin-2	NN	conj	B-protein
receptors	NNS	nsubj	I-protein
in	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	compound	I-cell_type
signal	NN	ROOT	O
through	IN	case	O
a	DT	det	O
MGF-STAT5-like	JJ	compound	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
developed	VBN	ROOT	O
a	DT	det	O
system	NN	dobj	O
to	TO	mark	O
monitor	VB	acl	O
the	DT	det	O
transcriptional	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
NFAT-1	NN	nmod	B-protein
at	IN	case	O
the	DT	det	O
single	JJ	amod	O
cell	NN	compound	O
level	NN	nmod	O
in	IN	case	O
whole	JJ	amod	O
animals	NNS	nmod	O
.	.	punct	O

The	DT	det	O
transcriptional	JJ	amod	O
activity	NN	nsubj	O
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
requires	VBZ	ROOT	O
T-cell	NN	compound	B-cell_type
costimulation	NN	dobj	O
delivered	VBN	acl	O
by	IN	case	O
the	DT	det	O
TCR	NN	nmod	B-protein
and	CC	cc	O
the	DT	det	O
auxiliary	JJ	amod	B-protein
receptor	NN	compound	I-protein
CD28	NN	conj	I-protein
.	.	punct	O

The	DT	det	O
Janus	NN	compound	B-protein
family	NN	compound	I-protein
tyrosine	NN	compound	I-protein
kinase	NN	compound	I-protein
Jak3	NN	nsubj	B-protein
is	VBZ	cop	O
the	DT	det	O
only	JJ	amod	O
signaling	VBG	amod	O
molecule	NN	ROOT	O
known	VBN	acl	O
to	TO	mark	O
be	VB	auxpass	O
associated	VBN	xcomp	O
with	IN	case	O
gamma	NN	compound	B-protein
c	NN	nmod	I-protein
,	,	punct	O
so	CC	advmod	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
hypothesized	VBN	conj	O
that	IN	mark	O
defects	NNS	nsubj	O
in	IN	case	O
Jak3	NN	nmod	B-protein
might	MD	aux	O
cause	VB	ccomp	O
an	DT	det	O
XSCID-like	JJ	amod	O
phenotype	NN	dobj	O
.	.	punct	O

The	DT	det	O
5	CD	nummod	B-DNA
'	``	punct	I-DNA
flanking	JJ	amod	I-DNA
DNA	NN	nsubj	I-DNA
also	RB	advmod	O
contains	VBZ	ROOT	O
a	DT	det	O
cluster	NN	dobj	O
of	IN	case	O
three	CD	nummod	O
binding	VBG	amod	B-DNA
sites	NNS	nmod	I-DNA
for	IN	case	O
the	DT	det	O
GATA	NN	compound	B-protein
family	NN	nmod	I-protein
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
.	.	punct	O

Activation	NN	ROOT	O
of	IN	case	O
human	JJ	amod	B-cell_line
CD4	NN	compound	I-cell_line
T	NN	compound	I-cell_line
lymphocytes	NNS	nmod	I-cell_line
.	.	punct	O

A	DT	det	O
comparison	NN	nsubjpass	O
with	IN	case	O
the	DT	det	O
Stat	NN	compound	B-protein
proteins	NNS	nmod	I-protein
induced	VBN	acl	O
by	IN	case	O
interferon-gamma	NN	nmod	B-protein
,	,	punct	O
PRL	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
IL-6	NN	conj	B-protein
in	IN	case	O
T47D	NN	compound	B-cell_line
mammary	JJ	amod	I-cell_line
tumor	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
was	VBD	auxpass	O
made	VBN	ROOT	O
.	.	punct	O

Several	JJ	amod	O
models	NNS	nsubjpass	O
are	VBP	auxpass	O
suggested	VBN	ROOT	O
for	IN	mark	O
how	WRB	advmod	O
elevated	JJ	amod	O
NF-IL6	NN	nsubj	B-protein
may	MD	aux	O
participate	VB	advcl	O
in	IN	case	O
an	DT	det	O
autostimulatory	JJ	amod	O
loop	NN	nmod	O
involving	VBG	acl	O
HIV	NN	compound	O
infection	NN	dobj	O
,	,	punct	O
macrophage	NN	compound	O
activation	NN	conj	O
,	,	punct	O
cytokine	NN	compound	B-protein
expression	NN	conj	O
,	,	punct	O
and	CC	cc	O
HIV	NN	compound	O
replication	NN	conj	O
.	.	punct	O

The	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
multiple	JJ	amod	O
CREB	NN	compound	B-protein
isoforms	NNS	nmod	I-protein
with	IN	case	O
identical	JJ	amod	O
DNA-binding	JJ	amod	O
specificities	NNS	nmod	O
but	CC	cc	O
differences	NNS	conj	O
in	IN	case	O
the	DT	det	O
presumed	JJ	amod	O
regulatory	JJ	amod	B-protein
domain	NN	nmod	I-protein
raises	VBZ	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
CREB	NN	compound	B-protein
proteins	NNS	nsubj	I-protein
may	MD	aux	O
be	VB	cop	O
able	JJ	ccomp	O
to	TO	mark	O
integrate	VB	xcomp	O
distinct	JJ	amod	O
regulatory	JJ	amod	O
signals	NNS	dobj	O
at	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
gene	NN	compound	O
transcription	NN	nmod	O
.	.	punct	O

Hematopoietic	JJ	amod	O
tissues	NNS	nsubj	O
from	IN	case	O
these	DT	det	O
mice	NNS	nmod	O
display	VBP	ROOT	O
elevated	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
both	CC	cc:preconj	O
nuclear	JJ	amod	B-protein
NF-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
and	CC	cc	O
mRNAs	NNS	conj	B-RNA
of	IN	case	O
some	DT	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
all	DT	conj	O
,	,	punct	O
genes	NNS	dobj	O
thought	VBN	acl	O
to	TO	mark	O
be	VB	auxpass	O
regulated	VBN	xcomp	O
by	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
.	.	punct	O

Immunosuppression	NN	ROOT	O
by	IN	case	O
glucocorticoids	NNS	nmod	O
:	:	punct	O
inhibition	NN	dep	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activity	NN	nmod	O
through	IN	case	O
induction	NN	nmod	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
synthesis	NN	nmod	O
[	-LRB-	punct	O
see	VB	dep	O
comments	NNS	dobj	O
]	-RRB-	punct	O

The	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
CD4	NN	nmod	B-protein
,	,	punct	O
a	DT	det	O
marker	NN	appos	O
for	IN	case	O
T-derived	JJ	amod	B-cell_type
lymphoid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
was	VBD	cop	O
not	RB	neg	O
significantly	RB	advmod	O
different	JJ	ROOT	O
in	IN	case	O
serum-free	JJ	amod	O
medium	NN	nmod	O
.	.	punct	O

This	DT	det	O
complementary	JJ	amod	B-DNA
DNA	NN	nsubj	I-DNA
encoded	VBD	ROOT	O
a	DT	det	O
protein	NN	dobj	O
with	IN	case	O
structural	JJ	amod	O
similarities	NNS	nmod	O
to	TO	case	O
the	DT	det	O
c-jun	NN	compound	B-protein
proto-oncogene	NN	compound	I-protein
product	NN	nmod	I-protein
,	,	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
target	NN	compound	O
sequence	NN	nsubj	O
was	VBD	cop	O
closely	RB	advmod	O
related	JJ	conj	O
to	TO	case	O
the	DT	det	O
palindromic	JJ	amod	B-DNA
target	NN	compound	I-DNA
sequence	NN	nmod	I-DNA
of	IN	case	O
c-jun	NN	nmod	B-DNA
.	.	punct	O

An	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
effect	NN	nsubjpass	O
of	IN	case	O
aldosterone	NN	nmod	O
on	IN	case	O
intracellular	JJ	amod	O
sodium	NN	nmod	O
,	,	punct	O
potassium	NN	conj	O
and	CC	cc	O
calcium	NN	conj	O
concentrations	NNS	dep	O
and	CC	cc	O
cell	NN	compound	O
volume	NN	conj	O
was	VBD	auxpass	O
shown	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
leukocytes	NNS	nmod	I-cell_type
.	.	punct	O

Concentration	NN	nsubjpass	O
of	IN	case	O
receptors	NNS	nmod	O
of	IN	case	O
hormonal	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
minimal	JJ	xcomp	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
under	IN	case	O
conditions	NNS	nmod	O
of	IN	case	O
chronic	JJ	amod	O
kidney	NN	compound	O
insufficiency	NN	nmod	O
,	,	punct	O
while	IN	mark	O
their	PRP$	nmod:poss	O
expression	NN	nsubjpass	O
,	,	punct	O
after	IN	case	O
the	DT	det	O
dioxyvit	NN	compound	O
action	NN	nmod	O
,	,	punct	O
was	VBD	auxpass	O
detected	VBN	advcl	O
only	RB	advmod	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
glomerulonephritis	NN	nmod	O
.	.	punct	O

The	DT	det	O
capacity	NN	nsubj	O
of	IN	case	O
the	DT	det	O
receptor	NN	nmod	B-protein
for	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
was	VBD	cop	O
low	JJ	ROOT	O
in	IN	case	O
Ro-VDR	NN	nmod	B-cell_line
.	.	punct	O

The	DT	det	O
cells	NNS	compound	O
lines	NNS	nsubj	O
described	VBN	acl	O
here	RB	advmod	O
should	MD	aux	O
be	VB	cop	O
useful	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
delineation	NN	nmod	O
of	IN	case	O
signaling	NN	compound	O
pathways	NNS	nmod	O
utilized	VBN	acl	O
in	IN	case	O
the	DT	det	O
selective	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

As	IN	prep	O
one	CD	nummod	O
test	NN	pobj	O
of	IN	case	O
this	DT	det	O
hypothesis	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
compared	VBD	ROOT	O
the	DT	det	O
abilities	NNS	dobj	O
of	IN	case	O
E1A	NN	compound	B-protein
-and	NN	compound	O
E7	NN	compound	B-protein
-expressing	JJ	amod	O
human	JJ	amod	B-cell_line
fibroblastic	JJ	amod	I-cell_line
or	CC	cc	I-cell_line
keratinocyte-derived	JJ	conj	I-cell_line
human	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
to	TO	mark	O
be	VB	auxpass	O
selectively	RB	advmod	O
killed	VBN	acl	O
by	IN	case	O
either	CC	cc:preconj	O
unstimulated	JJ	nmod	B-cell_type
or	CC	cc	O
interferon	NN	compound	B-cell_line
(	-LRB-	punct	I-cell_line
IFN	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
-activated	JJ	amod	I-cell_line
NK	NN	compound	I-cell_line
cells	NNS	dep	I-cell_line
.	.	punct	O

Interleukin-7	NN	nsubj	B-protein
can	MD	aux	O
induce	VB	ROOT	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
Jak	NN	nmod	B-protein
1	CD	nummod	I-protein
,	,	punct	O
Jak	NN	appos	B-protein
3	CD	nummod	I-protein
and	CC	cc	O
STAT	NN	compound	B-protein
5	CD	nummod	I-protein
proteins	NNS	conj	I-protein
in	IN	case	O
murine	JJ	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
half-life	NN	nsubj	O
of	IN	case	O
c-jun	NN	compound	B-RNA
RNA	NN	nmod	I-RNA
in	IN	case	O
TPA-treated	JJ	amod	B-cell_line
HL-60	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
exposed	VBN	acl	O
to	TO	case	O
cycloheximide	NN	nmod	O
and	CC	cc	O
actinomycin	NN	compound	O
D	NN	conj	O
was	VBD	cop	O
greater	JJR	ROOT	O
than	IN	case	O
2	CD	nummod	O
h	NN	nmod	O
.	.	punct	O

Cyclosporin	NN	compound	O
A	NN	nsubj	O
and	CC	cc	O
FK506	NN	conj	O
inhibited	VBD	ROOT	O
only	RB	advmod	O
transcriptional	JJ	amod	O
activation	NN	dobj	O
that	WDT	nsubj	O
was	VBD	cop	O
dependent	JJ	acl:relcl	O
on	IN	case	O
Ca2+	NN	compound	O
mobilization	NN	nmod	O
.	.	punct	O

As	IN	mark	O
shown	VBN	advcl	O
by	IN	case	O
mobility-shift	NN	amod	O
,	,	punct	O
methylation	NN	compound	O
interference	NN	conj	O
,	,	punct	O
and	CC	cc	O
mutational	JJ	amod	O
analyses	NNS	nmod	O
,	,	punct	O
the	DT	det	O
mammalian	JJ	amod	B-protein
protein	NN	compound	I-protein
BSAP	NN	nsubj	B-protein
recognizes	VBZ	ROOT	O
all	DT	det	O
four	CD	nummod	O
sea	NN	compound	B-DNA
urchin	NN	compound	I-DNA
binding	NN	compound	I-DNA
sites	NNS	dobj	I-DNA
in	IN	case	O
a	DT	det	O
manner	NN	nmod	O
indistinguishable	JJ	amod	O
from	IN	case	O
TSAP	NN	nmod	B-protein
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
two	CD	nummod	O
proteins	NNS	nsubj	O
differ	VBP	parataxis	O
in	IN	case	O
molecular	JJ	amod	O
weight	NN	nmod	O
.	.	punct	O

The	DT	det	O
exon-intron	JJ	amod	B-DNA
structure	NN	nsubjpass	I-DNA
of	IN	case	O
the	DT	det	O
5	CD	nummod	B-DNA
'	POS	punct	I-DNA
portion	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
thromboxane	NN	compound	B-DNA
receptor	NN	compound	I-DNA
gene	NN	nmod	I-DNA
was	VBD	auxpass	O
determined	VBN	ROOT	O
initially	RB	advmod	O
by	IN	mark	O
comparing	VBG	advcl	O
the	DT	det	O
nucleotide	NN	compound	B-DNA
sequence	NN	dobj	I-DNA
of	IN	case	O
the	DT	det	O
5	CD	nummod	B-DNA
'	``	punct	I-DNA
flanking	JJ	amod	I-DNA
genomic	JJ	amod	I-DNA
clone	NN	nmod	I-DNA
with	IN	case	O
that	DT	nmod	O
of	IN	case	O
a	DT	det	O
novel	JJ	amod	B-DNA
human	JJ	amod	I-DNA
uterine	NN	amod	I-DNA
thromboxane	NN	compound	I-DNA
receptor	NN	compound	I-DNA
cDNA	NN	nmod	I-DNA
that	WDT	nsubj	O
extended	VBD	acl:relcl	O
the	DT	det	O
mRNA	NN	dobj	B-RNA
141	CD	nummod	B-DNA
bp	NN	dep	I-DNA
further	RB	advmod	I-DNA
upstream	RB	advmod	I-DNA
than	IN	case	O
the	DT	det	O
previously	RB	advmod	B-DNA
identified	VBN	amod	I-DNA
human	JJ	amod	I-DNA
placental	JJ	amod	I-DNA
cDNA	NN	nmod	I-DNA
.	.	punct	O

At	IN	case	O
the	DT	det	O
end	NN	nmod	O
of	IN	case	O
this	DT	det	O
incubation	NN	nmod	O
the	DT	det	O
resting	VBG	amod	B-cell_type
cells	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
stimulated	VBN	ROOT	O
with	IN	case	O
M-CSF	NN	nmod	B-protein
,	,	punct	O
and	CC	cc	O
RNA	NN	nsubjpass	O
was	VBD	auxpass	O
isolated	VBN	conj	O
for	IN	case	O
analysis	NN	nmod	O
by	IN	case	O
Northern	NN	compound	O
blotting	NN	nmod	O
.	.	punct	O

From	IN	case	O
this	DT	nmod	O
and	CC	cc	O
other	JJ	amod	O
findings	NNS	conj	O
the	DT	det	O
picture	NN	nsubj	O
emerges	VBZ	ROOT	O
that	IN	mark	O
there	EX	expl	O
are	VBP	ccomp	O
at	IN	case	O
least	JJS	nmod:npmod	O
three	CD	nummod	O
categories	NNS	nsubj	O
of	IN	case	O
factors	NNS	nmod	O
which	WDT	nsubj	O
mediate	VBP	acl:relcl	O
cell-type-specific	JJ	amod	O
transcription	NN	dobj	O
in	IN	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
:	:	punct	O
(	-LRB-	punct	O
a	LS	det	O
)	-RRB-	punct	O
cell-specific	JJ	amod	B-protein
factors	NNS	dep	I-protein
such	JJ	case	O
as	IN	mwe	O
Oct-2A	NN	nmod	B-protein
and	CC	cc	O
Oct-2B	NN	conj	B-protein
that	WDT	nsubjpass	O
are	VBP	auxpass	O
not	RB	neg	O
expressed	VBN	acl:relcl	O
in	IN	case	O
most	JJS	amod	O
other	JJ	amod	O
cell	NN	compound	O
types	NNS	nmod	O
:	:	punct	O
(	-LRB-	punct	O
b	LS	dep	O
)	-RRB-	punct	O
ubiquitous	JJ	amod	B-protein
factors	NNS	dep	I-protein
such	JJ	case	O
as	IN	mwe	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
that	WDT	nsubj	O
are	VBP	cop	O
constitutively	RB	advmod	O
active	JJ	acl:relcl	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
but	CC	cc	O
are	VBP	auxpass	O
sequestered	VBN	conj	O
in	IN	case	O
an	DT	det	O
inactive	JJ	amod	O
form	NN	nmod	O
in	IN	case	O
other	JJ	amod	O
cells	NNS	nmod	O
;	:	punct	O
(	-LRB-	punct	O
c	LS	dep	O
)	-RRB-	punct	O
ubiquitously	RB	advmod	B-protein
active	JJ	amod	I-protein
factors	NNS	dep	I-protein
,	,	punct	O
exemplified	VBN	acl	O
by	IN	case	O
the	DT	det	O
one	CD	nummod	O
binding	VBG	nmod	O
to	TO	case	O
the	DT	det	O
E3	NN	compound	B-DNA
sequence	NN	compound	I-DNA
motif	NN	nmod	I-DNA
.	.	punct	O

Using	VBG	advcl	O
a	DT	det	O
combination	NN	dobj	O
of	IN	case	O
transfection	NN	nmod	O
,	,	punct	O
protein-DNA	JJ	amod	O
binding	NN	conj	O
,	,	punct	O
and	CC	cc	O
in	FW	amod	O
vitro	FW	dep	O
transcription	NN	compound	O
methods	NNS	conj	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
discovered	VBN	ROOT	O
the	DT	det	O
novel	JJ	amod	B-protein
T-cell-specific	JJ	amod	I-protein
transcriptional	JJ	amod	I-protein
activator	NN	dobj	I-protein
TCF-1	NN	dep	B-protein
(	-LRB-	punct	O
for	IN	case	O
T-Cell	NN	compound	B-protein
Factor-1	NN	appos	I-protein
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
recognizes	VBZ	dep	O
a	DT	det	O
T-cell-specific	JJ	amod	B-DNA
response	NN	compound	I-DNA
element	NN	dobj	I-DNA
(	-LRB-	punct	O
TCE	NN	appos	B-DNA
)	-RRB-	punct	O
located	JJ	amod	O
within	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Quantitative	JJ	amod	O
immunohistochemical	JJ	amod	O
analysis	NN	ROOT	O
of	IN	case	O
mononuclear	JJ	amod	B-cell_type
infiltrates	NNS	nmod	I-cell_type
in	IN	case	O
breast	NN	compound	O
carcinomas	NNS	nmod	O
--	:	punct	O
correlation	NN	dep	O
with	IN	case	O
tumour	NN	compound	O
differentiation	NN	nmod	O
.	.	punct	O

The	DT	det	O
thromboxane	NN	compound	B-DNA
receptor	NN	compound	I-DNA
gene	NN	nsubj	I-DNA
has	VBZ	ROOT	O
neither	CC	cc:preconj	O
a	DT	det	O
TATA	NN	dobj	B-DNA
nor	CC	cc	O
a	DT	det	O
CAAT	NN	compound	B-DNA
consensus	NN	compound	I-DNA
site	NN	conj	I-DNA
.	.	punct	O

Organizational	JJ	amod	O
analysis	NN	ROOT	O
and	CC	cc	O
mapping	NN	conj	O
of	IN	case	O
protein	NN	compound	B-DNA
kinase	NN	compound	I-DNA
C	NN	compound	I-DNA
--	:	punct	I-DNA
responsive	JJ	amod	I-DNA
elements	NNS	nmod	I-DNA
regulating	VBG	acl	O
expression	NN	dobj	O
in	IN	case	O
platelets	NNS	nmod	B-cell_type
.	.	punct	O

This	DT	det	O
effect	NN	nsubjpass	O
is	VBZ	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
largely	RB	advmod	O
mediated	VBN	xcomp	O
through	IN	case	O
inactivation	NN	nmod	O
of	IN	case	O
the	DT	det	O
phosphatase	NN	compound	O
calcineurin	NN	nmod	B-protein
,	,	punct	O
which	WDT	nsubj	O
in	IN	case	O
turn	NN	nmod	O
inhibits	VBZ	acl:relcl	O
translocation	NN	dobj	O
of	IN	case	O
an	DT	det	O
NFAT	NN	compound	B-protein
component	NN	nmod	O
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	O
.	.	punct	O

While	IN	mark	O
Bik	NN	nsubj	B-protein
does	VBZ	aux	O
not	RB	neg	O
show	VB	advcl	O
overt	JJ	amod	O
homology	NN	dobj	O
to	TO	case	O
the	DT	det	O
BH1	NN	compound	B-protein
and	CC	cc	O
BH2	NN	conj	B-protein
conserved	JJ	amod	O
domains	NNS	nmod	O
characteristic	JJ	amod	O
of	IN	case	O
the	DT	det	O
Bcl-2	NN	compound	B-protein
family	NN	nmod	I-protein
,	,	punct	O
it	PRP	nsubj	O
does	VBZ	aux	O
share	VB	ROOT	O
a	DT	det	O
9	CD	nummod	O
amino	NN	compound	B-protein
acid	NN	compound	I-protein
domain	NN	dobj	I-protein
(	-LRB-	punct	O
BH3	NN	appos	B-protein
)	-RRB-	punct	O
with	IN	case	O
Bax	NN	nmod	B-protein
and	CC	cc	O
Bak	NN	conj	B-protein
which	WDT	nsubj	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
critical	JJ	amod	O
determinant	NN	acl:relcl	O
for	IN	case	O
the	DT	det	O
death-promoting	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
.	.	punct	O

The	DT	det	O
clinical	JJ	amod	O
significance	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
model	NN	nmod	O
was	VBD	auxpass	O
underlined	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
demonstration	NN	nmod	O
of	IN	case	O
absent	JJ	nmod	O
or	CC	cc	O
a	DT	det	O
decreased	VBN	amod	O
number	NN	conj	O
of	IN	case	O
mineralocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
and	CC	cc	O
the	DT	det	O
lack	NN	conj	O
of	IN	case	O
electrolyte	NN	compound	O
response	NN	nmod	O
to	TO	case	O
aldosterone	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
leukocytes	NNS	nmod	I-cell_type
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
pseudohypoaldosteronism	NN	nmod	O
and	CC	cc	O
aldosteronism	NN	conj	O
.	.	punct	O

This	DT	nsubj	O
indicates	VBZ	ROOT	O
the	DT	det	O
independency	NN	dobj	O
of	IN	case	O
the	DT	det	O
CR	NN	nmod	O
of	IN	case	O
GR	NN	nmod	B-protein
from	IN	case	O
that	DT	nmod	O
of	IN	case	O
cortisol	NN	nmod	O
.	.	punct	O

The	DT	det	O
induction	NN	nsubjpass	O
of	IN	case	O
STAT	NN	compound	B-protein
activity	NN	nmod	O
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
completely	RB	advmod	O
by	IN	case	O
pretreatment	NN	nmod	O
with	IN	case	O
either	CC	cc:preconj	O
cycloheximide	NN	nmod	O
or	CC	cc	O
cyclosporin	NN	compound	O
A	NN	conj	O
,	,	punct	O
thus	RB	advmod	O
indicating	VBG	xcomp	O
that	IN	mark	O
the	DT	det	O
induction	NN	nsubj	O
was	VBD	cop	O
due	JJ	case	O
to	TO	case	O
a	DT	det	O
secondary	JJ	amod	B-protein
factor	NN	ccomp	I-protein
produced	VBN	acl	O
by	IN	case	O
the	DT	det	O
activated	VBN	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
cloned	VBD	ROOT	O
the	DT	det	O
murine	JJ	amod	B-DNA
BCL6	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
mBCL6	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
cDNA	NN	dobj	I-DNA
from	IN	case	O
the	DT	det	O
muscle	NN	compound	B-DNA
cDNA	NN	compound	I-DNA
library	NN	nmod	I-DNA
using	VBG	acl	O
the	DT	det	O
human	JJ	amod	B-DNA
BCL6	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
hBCL6	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
cDNA	NN	dobj	I-DNA
as	IN	case	O
a	DT	det	O
probe	NN	nmod	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
investigate	VB	dep	O
the	DT	det	O
long-term	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
low	JJ	amod	O
doses	NNS	nmod	O
of	IN	case	O
flutamide	NN	nmod	O
on	IN	case	O
clinical	JJ	amod	O
and	CC	cc	O
hormonal	JJ	conj	O
parameters	NNS	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
on	IN	case	O
the	DT	det	O
androgen	NN	compound	B-protein
receptor	NN	compound	I-protein
status	NN	conj	O
,	,	punct	O
in	IN	case	O
hirsute	JJ	amod	O
women	NNS	nmod	O
.	.	punct	O

1	LS	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D2	NN	compound	O
production	NN	ROOT	O
by	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
alveolar	JJ	amod	B-cell_type
macrophages	NNS	conj	I-cell_type
recovered	VBN	acl	O
by	IN	case	O
lavage	NN	nmod	O
from	IN	case	O
normocalcemic	JJ	amod	O
patients	NNS	nmod	O
with	IN	case	O
tuberculosis	NN	nmod	O
.	.	punct	O

The	DT	det	O
HIV-2	NN	compound	B-DNA
LTR	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
contain	VB	xcomp	O
two	CD	nummod	O
enhancers	NNS	dobj	B-DNA
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
an	DT	det	O
involvement	NN	dobj	O
of	IN	case	O
BLR2	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
migration	NN	nmod	O
in	IN	case	O
activated	VBN	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
in	IN	case	O
viral	JJ	amod	O
pathogenesis	NN	conj	O
.	.	punct	O

GCR	NN	nsubjpass	B-protein
on	IN	case	O
MNL	NN	nmod	B-cell_type
,	,	punct	O
PML	NN	conj	B-cell_type
and	CC	cc	O
mixed	JJ	amod	B-cell_type
leucocytes	NNS	conj	I-cell_type
in	IN	case	O
5	CD	nummod	O
patients	NNS	nmod	O
were	VBD	auxpass	O
determined	VBN	ROOT	O
simultaneously	RB	advmod	O
,	,	punct	O
and	CC	cc	O
all	DT	nsubj	O
lowered	VBD	conj	O
from	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
.	.	punct	O

Complex	NN	nsubj	B-protein
1	CD	nummod	I-protein
results	VBZ	ROOT	O
from	IN	case	O
binding	NN	nmod	O
of	IN	case	O
a	DT	det	O
ubiquitous	JJ	amod	O
polypeptide	NN	nmod	O
that	WDT	nsubj	O
recognizes	VBZ	acl:relcl	O
the	DT	det	O
3	CD	nummod	B-DNA
'	POS	punct	I-DNA
portion	NN	dobj	I-DNA
of	IN	case	O
this	DT	det	O
sequence	NN	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
not	RB	neg	O
required	VBN	conj	O
for	IN	case	O
repression	NN	nmod	O
.	.	punct	O

Mutation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
hXBP-1	NN	compound	B-DNA
DNA	NN	compound	I-DNA
target	NN	compound	I-DNA
sequence	NN	nmod	I-DNA
decreased	VBD	ROOT	O
DR	NN	compound	B-DNA
alpha	NN	compound	I-DNA
promoter	NN	compound	I-DNA
activity	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

The	DT	det	O
expression	NN	compound	O
vector	NN	nsubjpass	O
was	VBD	auxpass	O
cotransfected	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
chloramphenicol	NN	compound	B-DNA
acetyl	NN	compound	I-DNA
transferase	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
CAT	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
reporter	NN	compound	I-DNA
gene	NN	nmod	I-DNA
regulated	VBN	acl	O
by	IN	case	O
the	DT	det	O
thymidine	NN	compound	B-DNA
kinase	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
containing	VBG	acl	O
GAL4	NN	compound	B-DNA
DNA	NN	compound	I-DNA
binding	NN	compound	I-DNA
sites	NNS	dobj	I-DNA
into	IN	case	O
NIH	NN	compound	B-cell_line
3T3	NN	nmod	I-cell_line
,	,	punct	O
293	CD	conj	B-cell_line
,	,	punct	O
K562	NN	conj	B-cell_line
,	,	punct	O
and	CC	cc	O
Jurkat	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
.	.	punct	O

The	DT	det	O
sexual	JJ	amod	O
difference	NN	nsubj	O
in	IN	case	O
the	DT	det	O
incidence	NN	nmod	O
of	IN	case	O
autoimmune	JJ	amod	O
diseases	NNS	nmod	O
has	VBZ	aux	O
remained	VBN	ROOT	O
an	DT	det	O
enigma	NN	dobj	O
for	IN	case	O
many	JJ	amod	O
years	NNS	nmod	O
.	.	punct	O

Constitutive	JJ	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	nsubjpass	O
of	IN	case	O
a	DT	det	O
130-kD	JJ	amod	B-protein
protein	NN	compound	I-protein
(	-LRB-	punct	O
s	NNS	nmod	O
)	-RRB-	punct	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
tax	NN	nmod:npmod	B-protein
transformed	JJ	amod	B-cell_line
fibroblast	NN	compound	I-cell_line
B	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
and	CC	cc	O
in	IN	case	O
HTLV-1	NN	compound	B-cell_line
transformed	JJ	amod	I-cell_line
human	JJ	amod	I-cell_line
lymphoid	JJ	amod	I-cell_line
lines	NNS	conj	I-cell_line
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
thymocytes	NNS	conj	B-cell_type
from	IN	case	O
Thy-tax	NN	compound	O
transgenic	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

Other	JJ	amod	O
unidentified	JJ	amod	O
ETS-like	JJ	amod	B-protein
factors	NNS	nsubj	I-protein
present	JJ	amod	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
are	VBP	cop	O
also	RB	advmod	O
capable	JJ	ROOT	O
of	IN	mark	O
binding	VBG	advcl	O
GM5	NN	dobj	B-DNA
.	.	punct	O

The	DT	det	O
clinical	JJ	amod	O
benefits	NNS	nsubj	O
of	IN	case	O
salicylates	NNS	nmod	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
several	JJ	amod	O
diseases	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
atherosclerosis	NN	nmod	O
and	CC	cc	O
rheumatoid	JJ	amod	O
arthritis	NN	conj	O
,	,	punct	O
may	MD	aux	O
be	VB	cop	O
related	JJ	ROOT	O
to	TO	case	O
their	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
reduce	VB	acl	O
monocyte	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
balance	NN	nmod	O
of	IN	case	O
cytokine	NN	compound	B-protein
production	NN	nmod	O
and	CC	cc	O
the	DT	det	O
signal	NN	compound	O
transducer	NN	compound	O
and	CC	cc	O
activator	NN	conj	O
of	IN	amod	O
transcription	NN	dep	O
(	-LRB-	punct	O
STAT	NN	compound	B-protein
)	-RRB-	punct	O
transcription	NN	compound	O
factor	NN	compound	O
activity	NN	nmod	O
by	IN	case	O
cytokines	NNS	nmod	B-protein
and	CC	cc	O
inflammatory	JJ	amod	O
synovial	JJ	amod	O
fluids	NNS	conj	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
difference	NN	nsubj	O
between	IN	case	O
the	DT	det	O
distribution	NN	nmod	O
of	IN	case	O
the	DT	det	O
VDR	NN	compound	B-protein
alleles	NNS	nmod	O
in	IN	case	O
the	DT	det	O
patient	NN	compound	O
population	NN	nmod	O
when	WRB	advmod	O
compared	VBN	advcl	O
with	IN	case	O
the	DT	det	O
normal	JJ	amod	O
population	NN	nmod	O
.	.	punct	O

TF	NN	compound	O
expression	NN	nsubjpass	O
by	IN	case	O
circulating	VBG	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
thrombotic	JJ	amod	O
and	CC	cc	O
inflammatory	JJ	conj	O
complications	NNS	nmod	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
diseases	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
compared	VBN	ROOT	O
the	DT	det	O
frequency	NN	dobj	O
of	IN	case	O
a	DT	det	O
restriction	NN	compound	B-DNA
fragment	NN	compound	I-DNA
length	NN	compound	I-DNA
polymorphism	NN	nmod	I-DNA
(	-LRB-	punct	O
Bsm	NN	compound	O
I	NN	appos	O
)	-RRB-	punct	O
associated	VBN	acl	O
with	IN	case	O
different	JJ	amod	O
alleles	NNS	nmod	O
of	IN	case	O
the	DT	det	O
VDR	NN	compound	B-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
a	DT	det	O
group	NN	nmod	O
of	IN	case	O
33	CD	nummod	O
well	RB	advmod	O
characterized	VBN	amod	O
absorptive	JJ	amod	O
hypercalciuric	NN	amod	O
patients	NNS	nmod	O
and	CC	cc	O
a	DT	det	O
group	NN	conj	O
of	IN	case	O
36	CD	nummod	O
normal	JJ	amod	O
race-	NN	amod	O
and	CC	cc	O
age-matched	JJ	conj	O
control	JJ	compound	O
subjects	NNS	nmod	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
supports	VBZ	ROOT	O
previous	JJ	amod	O
clinical	JJ	amod	O
observations	NNS	dobj	O
that	IN	mark	O
patients	NNS	nsubj	O
may	MD	aux	O
require	VB	acl:relcl	O
morning	NN	dobj	O
through	IN	case	O
evening	NN	compound	O
exposure	NN	nmod	O
to	TO	case	O
MP	NN	nmod	O
to	TO	mark	O
optimize	VB	xcomp	O
efficacy	NN	dobj	O
while	IN	mark	O
adrenal	JJ	amod	O
suppression	NN	nsubjpass	O
is	VBZ	aux	O
being	VBG	auxpass	O
minimized	VBN	advcl	O
.	.	punct	O

Expression	NN	compound	O
cloning	NN	ROOT	O
of	IN	case	O
c-Jun	NN	nmod	B-protein
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Sex-related	JJ	amod	O
influences	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
implicated	VBN	dep	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
vernal	JJ	amod	O
keratoconjunctivitis	NN	nmod	O
(	-LRB-	punct	O
VKC	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
an	DT	det	O
allergic	JJ	amod	O
eosinophilic	JJ	amod	O
disease	NN	appos	O
.	.	punct	O

Because	IN	mark	O
1	CD	pobj	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nsubj	O
can	MD	aux	O
improve	VB	advcl	O
the	DT	det	O
capacity	NN	dobj	O
of	IN	case	O
macrophages	NNS	nmod	B-cell_type
to	TO	mark	O
kill	VB	acl	O
mycobacteria	NNS	dobj	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
support	VBP	ROOT	O
the	DT	det	O
conclusion	NN	dobj	O
that	IN	mark	O
macrophage-lymphocyte	JJ	amod	O
interactions	NNS	nsubj	O
,	,	punct	O
mediated	VBN	acl	O
at	IN	advmod	O
least	JJS	mwe	O
in	IN	case	O
part	NN	nmod	O
by	IN	case	O
1	CD	pobj	O
,	,	punct	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
,	,	punct	O
may	MD	aux	O
be	VB	cop	O
an	DT	det	O
important	JJ	amod	O
component	NN	ccomp	O
of	IN	case	O
a	DT	det	O
successful	JJ	amod	O
antituberculous	JJ	amod	O
immune	JJ	amod	O
response	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
IL-2	NN	compound	B-protein
secretion	NN	nsubjpass	O
was	VBD	auxpass	O
increased	VBN	advcl	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
anti-CD28	JJ	amod	B-protein
MoAb	NN	nmod	I-protein
,	,	punct	O
neonatal	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
IL-2	NN	compound	B-protein
production	NN	nsubj	O
remained	VBD	ROOT	O
lower	JJR	xcomp	O
than	IN	case	O
in	IN	case	O
adults	NNS	nmod	O
.	.	punct	O

The	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
Tax	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
JPX9	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
resulted	VBD	ROOT	O
in	IN	case	O
about	RB	advmod	O
a	DT	det	O
twofold	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
the	DT	det	O
mRNA	NN	compound	B-RNA
expression	NN	compound	O
levels	NNS	nmod	O
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
basal	JJ	amod	O
level	NN	advcl	O
.	.	punct	O

The	DT	det	O
novel	JJ	amod	O
complex	NN	nsubj	O
is	VBZ	cop	O
distinct	JJ	ROOT	O
from	IN	case	O
that	DT	nmod	O
described	VBN	acl	O
previously	RB	advmod	O
as	IN	mark	O
binding	VBG	advcl	O
to	TO	case	O
B	NN	compound	B-DNA
cell	NN	compound	I-DNA
enhancer	NN	compound	I-DNA
sites	NNS	nmod	I-DNA
and	CC	cc	O
can	MD	aux	O
be	VB	auxpass	O
formed	VBN	conj	O
by	IN	case	O
addition	NN	nmod	O
of	IN	case	O
PU.1	NN	nmod	B-protein
to	TO	case	O
extracts	NNS	nmod	O
from	IN	case	O
certain	JJ	amod	O
nonmyeloid	JJ	amod	B-cell_type
cell	NN	compound	I-cell_type
types	NNS	nmod	I-cell_type
which	WDT	nsubj	O
do	VBP	aux	O
not	RB	neg	O
express	VB	acl:relcl	O
PU.1	NN	dobj	B-protein
,	,	punct	O
including	VBG	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
epithelial	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
from	IN	case	O
erythroid	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

The	DT	det	O
complementary	JJ	amod	B-DNA
DNAs	NNS	nsubj	I-DNA
are	VBP	cop	O
the	DT	det	O
products	NNS	ROOT	O
of	IN	case	O
distinct	JJ	amod	O
genes	NNS	nmod	O
,	,	punct	O
yet	CC	cc	O
both	CC	cc:preconj	O
ITF-1	NN	nsubj	B-protein
and	CC	cc	O
ITF-2	NN	conj	B-protein
are	VBP	cop	O
structurally	RB	advmod	O
and	CC	advmod	O
functionally	RB	advmod	O
similar	JJ	conj	O
.	.	punct	O

DNase	NN	compound	O
footprinting	NN	compound	O
analysis	NN	nsubj	O
corroborated	VBD	ROOT	O
the	DT	det	O
functional	JJ	amod	O
data	NNS	dobj	O
showing	VBG	acl	O
that	IN	mark	O
a	DT	det	O
lymphoid-specific	JJ	amod	B-protein
protein	NN	nsubj	I-protein
binds	VBZ	ccomp	O
to	TO	case	O
the	DT	det	O
microB	NN	compound	B-DNA
DNA	NN	compound	I-DNA
motif	NN	nmod	I-DNA
.	.	punct	O

Lymphocytes	NNS	nsubj	B-cell_line
are	VBP	cop	O
particularly	RB	advmod	O
susceptible	JJ	ROOT	O
to	TO	case	O
DNA	NN	nmod:npmod	O
damage-induced	JJ	amod	O
apoptosis	NN	nmod	O
,	,	punct	O
a	DT	det	O
response	NN	dep	O
which	WDT	nsubj	O
may	MD	aux	O
serve	VB	acl:relcl	O
as	IN	case	O
a	DT	det	O
form	NN	nmod	O
of	IN	case	O
'altruistic	JJ	amod	O
suicide	NN	nmod	O
'	''	punct	O
to	TO	mark	O
counter	VB	xcomp	O
their	PRP$	nmod:poss	O
intrinsic	JJ	amod	O
high	JJ	amod	O
potential	NN	dobj	O
for	IN	case	O
mutation	NN	nmod	O
and	CC	cc	O
clonal	JJ	amod	O
expansion	NN	conj	O
.	.	punct	O

The	DT	det	O
B4-2	NN	compound	B-DNA
clone	NN	nsubj	O
coded	VBD	ROOT	O
for	IN	case	O
an	DT	det	O
mRNA	NN	nmod	B-RNA
of	IN	case	O
2061	CD	nummod	O
bp	NN	nmod	O
in	IN	case	O
length	NN	nmod	O
.	.	punct	O

NF-kappa	NN	compound	B-protein
B	NN	nsubj	I-protein
binds	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
enhancer	NN	compound	I-DNA
region	NN	nmod	O
of	IN	case	O
the	DT	det	O
long	JJ	amod	B-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
and	CC	cc	O
contributes	VBZ	conj	O
to	TO	case	O
the	DT	det	O
inducibility	NN	nmod	O
of	IN	case	O
HIV-1	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
multiple	JJ	amod	O
activating	VBG	amod	O
agents	NNS	nmod	O
.	.	punct	O

The	DT	det	O
fusion	NN	compound	B-DNA
cDNA	NN	nsubj	I-DNA
results	VBZ	ROOT	O
from	IN	case	O
an	DT	det	O
interstitial	JJ	amod	O
deletion	NN	nmod	O
between	IN	case	O
a	DT	det	O
previously	RB	advmod	O
unknown	JJ	amod	B-DNA
locus	NN	nmod	I-DNA
,	,	punct	O
SIL	NN	appos	B-DNA
(	-LRB-	punct	O
SCL	NN	compound	B-DNA
interrupting	NN	compound	I-DNA
locus	NN	appos	I-DNA
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
5	CD	nummod	B-DNA
'	''	punct	I-DNA
untranslated	JJ	amod	I-DNA
region	NN	conj	I-DNA
of	IN	case	O
SCL	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
the	DT	det	O
fluctuations	NNS	nsubjpass	O
of	IN	case	O
type	NN	compound	B-protein
II	CD	nummod	I-protein
EBS	NNS	nmod	I-protein
during	IN	case	O
the	DT	det	O
menstrual	JJ	amod	O
cycle	NN	nmod	O
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
in	IN	case	O
6	CD	nummod	O
normally	RB	advmod	O
menstruating	VBG	amod	O
women	NNS	nmod	O
.	.	punct	O

Fourth	RB	advmod	O
,	,	punct	O
extensive	JJ	amod	O
purification	NN	nsubj	O
by	IN	case	O
several	JJ	amod	O
cycles	NNS	nmod	O
of	IN	case	O
TRE	NN	compound	B-DNA
-DNA	NN	compound	O
affinity	NN	compound	O
chromatography	NN	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	dep	O
32	CD	nmod	B-protein
,	,	punct	I-protein
36	CD	compound	I-protein
to	TO	dep	I-protein
42	CD	conj	I-protein
and	CC	cc	I-protein
110	CD	conj	I-protein
kD	NN	conj	I-protein
proteins	NNS	dep	I-protein
and	CC	cc	O
to	TO	case	O
less	JJR	advmod	O
extent	NN	conj	O
the	DT	det	O
50	CD	nummod	B-protein
kD	NN	compound	I-protein
factor	NN	dep	I-protein
.	.	punct	O

Now	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
report	VBP	ROOT	O
the	DT	det	O
solution	NN	compound	O
structure	NN	dobj	O
of	IN	case	O
the	DT	det	O
sequence-specific	JJ	amod	B-protein
HMG-box	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
SRY-related	JJ	amod	B-protein
protein	NN	nmod	I-protein
Sox-4	NN	dep	B-protein
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
now	RB	advmod	O
raised	VBN	ROOT	O
a	DT	det	O
monoclonal	JJ	amod	B-protein
antibody	NN	dobj	I-protein
to	TO	mark	O
document	VB	advcl	O
expression	NN	dobj	O
and	CC	cc	O
biochemistry	NN	conj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
TCF-1	NN	compound	I-protein
protein	NN	nmod	I-protein
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
endogenous	JJ	amod	B-protein
C/EBP	NN	compound	I-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
using	VBG	acl	O
either	CC	cc:preconj	O
an	DT	det	O
excess	NN	dobj	O
of	IN	case	O
C/EBP	NN	compound	B-DNA
binding	NN	compound	I-DNA
sites	NNS	nmod	I-DNA
or	CC	cc	O
a	DT	det	O
trans-	JJ	amod	B-DNA
dominant	JJ	amod	I-DNA
negative	JJ	amod	I-DNA
inhibitor	NN	conj	I-DNA
,	,	punct	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
C/EBP	NN	compound	B-protein
proteins	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
basal	JJ	amod	O
and	CC	cc	O
activated	VBN	conj	O
levels	NNS	nmod	O
of	IN	case	O
HIV-1	NN	compound	B-DNA
LTR	NN	compound	I-DNA
transcription	NN	nmod	O
in	IN	case	O
the	DT	det	O
promonocytic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
U937	NN	nmod	I-cell_line
.	.	punct	O

Type	NN	compound	B-protein
II	CD	nummod	I-protein
estrogen	NN	compound	I-protein
binding	NN	compound	I-protein
sites	NNS	ROOT	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
:	:	punct	O
variations	NNS	dep	O
during	IN	case	O
the	DT	det	O
menstrual	JJ	amod	O
cycle	NN	nmod	O
.	.	punct	O

Such	JJ	amod	O
tests	NNS	nsubj	O
may	MD	aux	O
become	VB	ROOT	O
useful	JJ	amod	O
diagnostic	JJ	amod	O
tools	NNS	attr	O
.	.	punct	O

Several	JJ	amod	O
lines	NNS	nsubj	O
of	IN	case	O
evidence	NN	nmod	O
have	VBP	aux	O
suggested	VBN	ROOT	O
that	IN	mark	O
NFAT	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
substrate	NN	ccomp	O
for	IN	case	O
calcineurin	NN	nmod	B-protein
,	,	punct	O
a	DT	det	O
serine/threonine	NN	compound	B-protein
phosphatase	NN	appos	I-protein
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
seeking	VBG	advcl	O
social	JJ	amod	O
support	NN	dobj	O
as	IN	case	O
a	DT	det	O
coping	NN	compound	O
strategy	NN	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
perceived	VBN	amod	O
quality	NN	conj	O
of	IN	case	O
support	NN	nmod	O
,	,	punct	O
also	RB	advmod	O
entered	VBD	ROOT	O
the	DT	det	O
model	NN	dobj	O
to	TO	mark	O
account	VB	acl	O
for	IN	case	O
a	DT	det	O
significant	JJ	amod	O
amount	NN	nmod	O
of	IN	case	O
NK	NN	compound	O
activity	NN	compound	O
variance	NN	nmod	O
(	-LRB-	punct	O
multivariate	JJ	amod	O
F	NN	dep	O
=	JJ	amod	O
5.25	CD	dobj	O
,	,	punct	O
p	NN	appos	O
less	JJR	amod	O
than	IN	case	O
0.001	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

TCL1	NN	compound	O
oncogene	NN	compound	O
activation	NN	ROOT	O
in	IN	case	O
preleukemic	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
a	DT	det	O
case	NN	nmod	O
of	IN	case	O
ataxia-telangiectasia	NN	nmod	O
.	.	punct	O

Receptor	NN	compound	O
mutant	JJ	amod	O
subclones	NNS	nsubj	O
of	IN	case	O
CEM-C7	NN	nmod	B-cell_line
,	,	punct	O
which	WDT	nsubjpass	O
are	VBP	auxpass	O
proven	VBN	acl:relcl	O
to	TO	mark	O
be	VB	cop	O
completely	RB	advmod	O
unresponsive	JJ	xcomp	O
to	TO	case	O
micromolar	JJ	amod	O
concentrations	NNS	nmod	O
of	IN	case	O
dexamethasone	NN	nmod	O
when	WRB	advmod	O
grown	VBN	advcl	O
in	IN	case	O
serum-supplemented	JJ	amod	O
medium	NN	nmod	O
,	,	punct	O
become	VBP	ROOT	O
partially	RB	advmod	O
sensitive	JJ	xcomp	O
to	TO	case	O
the	DT	det	O
hormone	NN	nmod	O
after	IN	case	O
growth	NN	nmod	O
in	IN	case	O
defined	VBN	amod	O
medium	NN	nmod	O
.	.	punct	O

Similar	JJ	amod	O
constructs	NNS	nsubj	O
controlled	VBN	acl	O
by	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
or	CC	cc	O
the	DT	det	O
entire	JJ	amod	O
interleukin-2	NN	compound	B-DNA
enhancer	NN	conj	I-DNA
show	VBP	ROOT	O
bimodal	JJ	amod	O
expression	NN	compound	O
patterns	NNS	dobj	O
during	IN	case	O
induction	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
thresholds	NNS	nsubj	O
set	VBN	acl	O
by	IN	case	O
the	DT	det	O
concentration	NN	nmod	O
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
common	JJ	amod	O
property	NN	ccomp	O
of	IN	case	O
inducible	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

Using	VBG	advcl	O
a	DT	det	O
polyclonal	JJ	amod	O
antibody	NN	dobj	O
to	TO	case	O
murine	JJ	amod	B-protein
NFATp	NN	nmod	I-protein
,	,	punct	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
various	JJ	amod	O
mouse	NN	compound	O
tissues	NNS	nmod	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
110-130-kDa	JJ	amod	O
NFATp	NN	compound	B-protein
protein	NN	nsubjpass	I-protein
was	VBD	auxpass	O
highly	RB	advmod	O
expressed	VBN	ccomp	O
in	IN	case	O
thymus	NN	nmod	O
and	CC	cc	O
spleen	NN	conj	O
.	.	punct	O

Progressive	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
cell	NN	compound	B-protein
surface	NN	compound	I-protein
maturation-specific	JJ	amod	I-protein
antigens	NNS	nmod	I-protein
of	IN	case	O
the	DT	det	O
monocyte/macrophage	NN	compound	B-cell_type
lineage	NN	nmod	I-cell_type
was	VBD	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
treatment	NN	nmod	O
of	IN	case	O
RWLeu-4	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
VD3	NN	nmod	O
for	IN	case	O
24	CD	compound	O
to	TO	dep	O
72	CD	nummod	O
h	NN	nmod	O
at	IN	case	O
doses	NNS	nmod	O
that	WDT	nsubj	O
inhibited	VBD	acl:relcl	O
cellular	JJ	amod	O
proliferation	NN	dobj	O
.	.	punct	O

Adherence	NN	nsubj	O
to	TO	case	O
either	CC	cc:preconj	O
fibronectin	NN	nmod	O
or	CC	cc	O
collagen-coated	JJ	amod	O
plastic	NN	conj	O
had	VBD	ROOT	O
little	JJ	amod	O
consistent	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
PDGF	NN	compound	B-RNA
(	-LRB-	punct	I-RNA
B	NN	compound	I-RNA
)	-RRB-	punct	I-RNA
mRNA	NN	compound	I-RNA
accumulation	NN	nmod	O
.	.	punct	O

1	LS	dep	O
)	-RRB-	punct	O
There	EX	expl	O
exists	VBZ	ROOT	O
a	DT	det	O
CR	NN	dobj	O
of	IN	case	O
GR	NN	nmod	B-protein
in	IN	case	O
human	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
,	,	punct	O
PMN	NN	appos	B-cell_type
,	,	punct	O
and	CC	cc	O
monocytes	NNS	conj	B-cell_type
with	IN	case	O
the	DT	det	O
peak	NN	amod	O
values	NNS	nmod	O
from	IN	case	O
0400	CD	compound	O
to	TO	dep	O
0800	CD	nummod	O
hr	NN	nmod	O
and	CC	cc	O
the	DT	det	O
trough	NN	compound	O
values	NNS	conj	O
between	IN	case	O
2300	CD	nummod	O
and	CC	cc	O
0000	CD	conj	O
hr	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
level	NN	nsubjpass	O
of	IN	case	O
jun	NN	compound	B-protein
protein	NN	nmod	I-protein
was	VBD	auxpass	O
elevated	VBN	ROOT	O
by	IN	case	O
2	CD	compound	O
to	TO	dep	O
5-fold	RB	nmod	O
within	IN	case	O
4	CD	nummod	O
h	NN	nmod	O
in	IN	case	O
HU	NN	nmod:npmod	B-cell_line
treated	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Point	NN	compound	O
mutation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
c-Myb	NN	compound	B-DNA
site	NN	nmod	I-DNA
within	IN	case	O
the	DT	det	O
intact	JJ	amod	O
2.3-kb	JJ	amod	B-protein
LCR	NN	nmod	I-protein
severely	RB	advmod	O
attenuated	VBD	ROOT	O
enhancer	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
transfections	NNS	nmod	O
and	CC	cc	O
LCR	NN	compound	B-DNA
activity	NN	conj	O
in	IN	case	O
transgenic	JJ	amod	B-cell_line
thymocytes	NNS	nmod	I-cell_line
.	.	punct	O

Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
ATL	NN	compound	B-cell_line
cells	NNS	nsubj	I-cell_line
overexpressed	VBD	ccomp	O
that	IN	dobj	O
L-selectin	NN	compound	B-RNA
mRNA	NN	dep	I-RNA
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
level	NN	nsubjpass	O
was	VBD	auxpass	O
aberrantly	RB	advmod	O
upregulated	VBN	conj	O
after	IN	case	O
PMA	NN	compound	O
stimulation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
present	VBP	ROOT	O
evidence	NN	dobj	O
that	IN	mark	O
IBR	NN	nsubj	B-protein
and	CC	cc	O
IBF	NN	conj	B-protein
are	VBP	cop	O
most	RBS	advmod	O
likely	RB	advmod	O
identical	JJ	amod	O
proteins	NNS	ccomp	O
,	,	punct	O
differing	VBG	acl	O
in	IN	case	O
their	PRP$	nmod:poss	O
degree	NN	nmod	O
of	IN	case	O
glycosylation	NN	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
previously	RB	advmod	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
lower	JJR	amod	O
affinity	NN	compound	O
class	NN	nsubj	O
of	IN	case	O
sites	NNS	nmod	O
are	VBP	cop	O
similar	JJ	ccomp	O
in	IN	case	O
affinity	NN	nmod	O
and	CC	cc	O
site	NN	compound	O
molarity	NN	conj	O
to	TO	case	O
those	DT	nmod	O
recognized	VBN	acl	O
by	IN	case	O
dexamethasone	NN	nmod	O
.	.	punct	O

The	DT	det	O
sequence	NN	nsubj	O
of	IN	case	O
one	CD	nmod	O
of	IN	case	O
these	DT	det	O
elements	NNS	nmod	B-DNA
,	,	punct	O
OSE2	NN	appos	O
,	,	punct	O
is	VBZ	cop	O
identical	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
DNA-binding	JJ	amod	B-DNA
site	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
PEBP2	NN	compound	B-protein
alpha/AML-1	NN	compound	I-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
,	,	punct	O
the	DT	det	O
mammalian	JJ	amod	B-protein
homologues	NNS	dobj	I-protein
of	IN	case	O
the	DT	det	O
Drosophila	FW	compound	B-protein
Runt	NN	compound	I-protein
protein	NN	nmod	I-protein
.	.	punct	O

Rex	NN	nsubjpass	B-protein
,	,	punct	O
the	DT	det	O
post-transcriptional	JJ	amod	B-protein
regulator	NN	appos	I-protein
of	IN	case	O
human	JJ	amod	O
T-cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	nmod	O
I	CD	nummod	O
(	-LRB-	punct	O
HTLV-I	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
accumulation	NN	dobj	O
of	IN	case	O
the	DT	det	O
unspliced	JJ	amod	B-RNA
viral	JJ	amod	I-RNA
gag-pol	NN	compound	I-RNA
mRNA	NN	nmod	I-RNA
.	.	punct	O

A	DT	det	O
variety	NN	nsubj	O
of	IN	case	O
other	JJ	amod	O
cells	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
transformed	VBN	amod	B-cell_type
erythroid	JJ	amod	I-cell_type
precursors	NNS	nmod	I-cell_type
,	,	punct	O
do	VBP	aux	O
not	RB	neg	O
have	VB	ROOT	O
IBR	NN	dobj	B-protein
but	CC	cc	O
a	DT	det	O
factor	NN	conj	O
referred	VBN	acl	O
to	TO	nmod	O
as	IN	case	O
IBF	NN	nmod	B-protein
(	-LRB-	punct	O
68	CD	compound	O
to	TO	dep	O
70	CD	nummod	O
kDa	NN	appos	O
)	-RRB-	punct	O
that	WDT	nsubj	O
recognizes	VBZ	acl:relcl	O
the	DT	det	O
same	JJ	amod	O
IBR	NN	compound	B-protein
sites	NNS	dobj	O
.	.	punct	O

When	WRB	advmod	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
activated	VBN	advcl	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
,	,	punct	O
the	DT	det	O
levels	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
mature	JJ	amod	O
protein	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
its	PRP$	nmod:poss	O
precursor	NN	conj	O
were	VBD	auxpass	O
decreased	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
response	NN	dep	O
to	TO	case	O
secondary	JJ	amod	O
pathogenic	JJ	amod	O
infections	NNS	nmod	O
or	CC	cc	O
antigenic	JJ	amod	O
challenge	NN	conj	O
,	,	punct	O
cytokine	NN	compound	B-protein
gene	NN	compound	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
rapidly	RB	advmod	O
induced	VBN	ROOT	O
,	,	punct	O
enhanced	VBN	conj	O
,	,	punct	O
and	CC	cc	O
sustained	JJ	conj	O
over	IN	case	O
prolonged	JJ	amod	O
periods	NNS	nmod	O
in	IN	case	O
HIV-1-infected	JJ	amod	B-cell_line
myeloid	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
compared	VBN	case	O
with	IN	case	O
uninfected	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

HIV-1	NN	compound	O
infection	NN	nsubj	O
of	IN	case	O
myeloid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
can	MD	aux	O
lead	VB	ROOT	O
to	TO	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
surface	NN	compound	B-protein
receptors	NNS	nmod	I-protein
associated	VBN	acl	O
with	IN	case	O
cellular	JJ	amod	O
activation	NN	nmod	O
and/or	CC	cc	O
differentiation	NN	conj	O
that	WDT	nsubj	O
increase	VBP	acl:relcl	O
the	DT	det	O
responsiveness	NN	dobj	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
to	TO	case	O
cytokines	NNS	nmod	B-protein
secreted	VBN	acl	O
by	IN	case	O
neighboring	VBG	amod	O
cells	NNS	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
to	IN	case	O
bacteria	NNS	conj	O
or	CC	cc	O
other	JJ	amod	O
pathogens	NNS	conj	O
.	.	punct	O

Initiation	NN	compound	B-protein
binding	NN	compound	I-protein
repressor	NN	nsubj	I-protein
,	,	punct	O
a	DT	det	O
factor	NN	appos	O
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
transcription	NN	compound	B-DNA
initiation	NN	compound	I-DNA
site	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
histone	NN	compound	B-DNA
h5	NN	compound	I-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
glycosylated	VBN	amod	B-protein
member	NN	ROOT	I-protein
of	IN	case	O
a	DT	det	O
family	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-protein
growth	NN	compound	I-protein
regulators	NNS	nmod	I-protein
[	-LRB-	punct	O
corrected	VBN	dep	O
]	-RRB-	punct	O
[	-LRB-	punct	O
published	VBN	amod	O
erratum	NN	nsubj	O
appears	VBZ	dep	O
in	IN	case	O
Mol	NNP	compound	O
Cell	NNP	compound	O
Biol	NNP	compound	O
1996	CD	nummod	O
Feb	NNP	nmod	O
;	:	punct	O
16	CD	nummod	O
(	-LRB-	punct	O
2	CD	dep	O
)	-RRB-	punct	O
:	:	punct	O
735	CD	dep	O
]	-RRB-	punct	O

These	DT	det	O
results	NNS	nsubj	O
define	VBP	ROOT	O
distinct	JJ	amod	O
roles	NNS	dobj	O
for	IN	case	O
the	DT	det	O
two	CD	nummod	O
forms	NNS	nmod	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
and	CC	cc	O
demonstrate	VBP	conj	O
the	DT	det	O
necessity	NN	dobj	O
for	IN	case	O
stringent	JJ	amod	O
control	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
.	.	punct	O

Deletional	JJ	amod	O
analysis	NN	nsubj	O
and	CC	cc	O
site-directed	JJ	amod	O
mutagenesis	NN	conj	O
of	IN	case	O
the	DT	det	O
EA-D	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
demonstrated	VBD	ROOT	O
that	IN	mark	O
in	IN	case	O
epithelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
the	DT	det	O
potential	JJ	amod	O
AP-1	NN	compound	B-DNA
binding	NN	compound	I-DNA
site	NN	nsubj	I-DNA
plays	VBZ	ccomp	O
an	DT	det	O
essential	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
Z	NN	compound	B-protein
responsiveness	NN	nmod	O
,	,	punct	O
although	IN	mark	O
sequences	NNS	nsubj	O
further	RB	advmod	O
upstream	JJ	advmod	O
are	VBP	cop	O
also	RB	advmod	O
important	JJ	advcl	O
.	.	punct	O

The	DT	det	O
carboxyl-terminal	JJ	amod	B-protein
181	CD	nummod	I-protein
amino	NN	compound	I-protein
acids	NNS	nsubj	I-protein
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
TFIID	NN	compound	I-protein
protein	NN	nmod	I-protein
shares	VBZ	ROOT	O
80	CD	nummod	O
%	NN	compound	O
identity	NN	dobj	O
with	IN	case	O
the	DT	det	O
TFIID	NN	compound	B-protein
protein	NN	nmod	O
from	IN	case	O
Saccharomyces	FW	compound	O
cerevisiae	FW	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
examined	VBN	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
CD28	NN	nmod	B-protein
in	IN	mark	O
modulating	VBG	acl	O
the	DT	det	O
'naive	JJ	amod	O
'	``	punct	O
neonatal	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
response	NN	dobj	O
to	TO	case	O
anti-CD2	JJ	amod	B-protein
-mediated	JJ	amod	O
activation	NN	nmod	O
.	.	punct	O

Accordingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
same	JJ	amod	O
set	NN	nsubj	O
of	IN	prep	O
words	NNS	pobj	O
and	CC	cc	O
phrases	NNS	conj	O
(	-LRB-	punct	O
oligopeptides	NNS	appos	O
)	-RRB-	punct	O
appear	VBP	ROOT	O
in	IN	case	O
totally	RB	advmod	O
unrelated	JJ	amod	O
proteins	NNS	nmod	O
.	.	punct	O

Transfections	NNS	nsubj	O
of	IN	case	O
E3	NN	compound	B-DNA
constructs	NNS	nmod	I-DNA
linked	VBN	acl	O
to	TO	case	O
the	DT	det	O
chloramphenicol	NN	compound	B-DNA
acetyltransferase	NN	compound	I-DNA
gene	NN	nmod	I-DNA
revealed	VBD	ROOT	O
that	IN	mark	O
mutagenesis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
distal	JJ	amod	B-DNA
NF-kappa	NN	compound	I-DNA
B	NN	compound	I-DNA
motif	NN	nmod	I-DNA
(	-LRB-	punct	O
L2	NN	appos	B-DNA
)	-RRB-	punct	O
had	VBD	ccomp	O
minimal	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
promoter	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
HeLa	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
but	CC	cc	O
resulted	VBD	conj	O
in	IN	case	O
dramatic	JJ	amod	O
decreases	NNS	nmod	O
in	IN	case	O
expression	NN	nmod	O
by	IN	case	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

